In the Footsteps of the Rugged Trail of Transcription by Han, R. (Ruiqi)
In the Footsteps of the Rugged Trail of Transcription
Ruiqi Han
In the Footsteps of the Rugged Trail of Transcription
In de voetstappen van het ruige pad van transcriptie
Thesis
to obtain the degree of Doctor from the
Erasmus University Rotterdam
by command of the
rector magnificus
Prof.dr. R.C.M.E. Engels
and in accordance with the decision of the Doctorate Board.
The public defence shall be held on
Thursday 14th of February, 2019 at 13:30 hrs
by
Ruiqi Han
born in Changchun, China
Printing: ProefschriftMaken || www.proefschriftmaken.nl
Lay out: Lieve Stiers
Cover Design: Caiqiu Yang and Ruiqi Han
ISBN 978-94-6380-190-4
© 2018 Ruiqi Han
All rights reserved. No part of this publication may be reproduced, stored in a 
retrieval system or transmitted, in any form or by any means, electronic, mechanical, 
photocopying, recording or otherwise, without prior permission of the author or 
the copyright-owning journals for previous published chapters.
Doctoral Committee
Promotor: prof.dr. R. Agami
Other members: prof.dr. C.P. Verrijzer
 prof.dr. W.T. Zwart
 Dr. R.A. Poot
Copromotor: Dr. B. Slododin
TABLE OF 
CONTENTS
Chapter 1 General introduction 9
Chapter 2 Transcription impacts the efficacy of mRNA translation via  
co-transcriptional N6-adenosine methylation 25
Chapter 3 The methylated way to translation 71
Chapter 4 Functional CRISPR Screen Identifies AP1-associated Enhancer 
regulating FOXF1 to modulate  
Oncogene-Induced Senescence 77
Chapter 5 General discussion 109
Summary  117
Samenvatting 121
Curriculum vitae 125
List of publications 127
Acknowledgements 131
List of Abbreviations
bp Base pair
DNA Deoxyribonucleic acid
RNA Ribonucleic acid
Gro-seq Global run-on sequencing
RNA Pol II RNA polymerase II
PAM protospacer adjacent motif
m6A N6-methyl-adenosine
CRISPR Clustered Regularly Interspaced Short Palindromic Repeats
TE Translational efficiency
mRNA Messenger RNA
eRNA Enhancer RNA
TF Transcription factor
UTR Untranslated region
OIS Oncogene-induced senescence
1
CHAPTER 1
General introduction
Chapter 1 General introduction
1110
1
From DNA, RNA to protein
Nature has created numerous different forms of life on the planet, as seen by 
their appearances, living habits, and reproduction methods. Among all the existing 
lifeforms and creatures, there is one common trace of life that remains after billions 
of years of evolution: DNA. The history of our past and the path to our future are 
largely determined by genetic information, which is considered the DNA sequence 
of bases along a nucleic-acid chain (Berg et al., 2002, chapter 5). In human cells, 
there are two copies of each chromosome, a result of the fusion of sperm and egg 
cells. To interpret its information, the double helix DNA is transcribed into a single-
strand RNA. The series of events occur inside the nucleus of every cell. Those RNA 
codes for specific proteins, namely mRNA, are then exported to the cytoplasm to 
be translated into proteins. The cellular and physiological functions of our body 
are highly dependent on the proper production and regulation of proteins. 
Transcription regulation
The human genome contains about 20,000 protein-coding genes and even more 
non-coding genes (Djebali et al., 2012) through which the transcription takes place. 
The process of transcription initiating at the sequences is termed ‘promoters’. 
These include the transcription start site, TATA box, and transcription regulatory 
regions as the core elements (Lee and Young, 2000). The strength of the promoters 
partially governs the transcriptional potential. The transcription is further 
regarded as a combinatorial interaction of many different processes, including 
the recruitment of chromatin remodelers, polymerases, acetyltransferases, 
methyltransferases, etc (Coulon et al., 2013). The mystery of these collaborative 
actions remains mostly unknown considering the dynamics of transcription. 
Each human cell comprises more than six billion nucleotides packed into a tiny 
nucleus of just a few µm (Gillooly et al., 2015).  The contents of the nucleus 
require highly organized structures to maintain viable cellular functions. The 
cells handle the long stretches of DNA by wrapping them around the chromatin, 
or more specifically, the nucleosomes. Each nucleosome includes two pairs of 
the four core histone proteins, H2A, H2B, H3, and H4, with two meters of DNA 
compacted inside (Li and Reinberg, 2011). The physical barrier of histones blocks 
the accessibility of transcription factors. In addition, this also prevents the RNA 
polymerases from initiating transcription. This suggests how exactly DNA is 
wrapped around the histones is tightly controlled. These histone molecules harbor 
various post-translation modifications (methylation, acetylation, phosphorylation, 
ubiquitination, etc.) that govern the compaction and accessibility of DNA (Lawrence 
et al., 2016) (see also Figure 1a). 
Typically, the types of chromatin are divided into heterochromatin and 
euchromatin. Heterochromatin is denser and transcription-inactive, whereas 
euchromatin has a more relaxed structure for active transcription (Lelli et al., 
2012). Within the gene-rich euchromatin, the transcription of coding genes is 
largely coordinated by transcription factors (TF) and RNA polymerase II (Pol II) 
machinery (Figure 1b). The promoter region acts as a dock for sequence-specific 
TFs, which determine numerous cellular functions, including differentiation, 
stress-response, and proliferation. Moreover, a single TF regulate different genes 
in a distinct cellular context, suggesting the regulatory network of transcription is 
very dynamic (Lambert et al., 2018). The recruitment of different TFs and cofactors 
relays the genetic information to different transcription initiation factors. Upon 
the stepwise assembly of the transcription initiation complex (TFIIB, TFIIF, TFIIE, 
TFIIH, RNA Pol II, etc.) (Kadonaga, 2004), RNA Pol II is released to elongate along 
the DNA template (Figure 1c). 
While RNA Pol II elongates along the DNA, the splicing of the pre-mRNA happens 
co-transcriptionally and requires multiple spliceosomes to remove introns from 
the nascent transcript (Herzel et al., 2017) (Figure 1d). A mammalian spliceosome 
consists of U1, U2, U4, U5, and U6 small nuclear RNPs (snRNPs), together with a 
large set of supplementary factors (Stark and Lührmann, 2006). Assembly of the 
spliceosome is associated with the C-terminal domain (CTD) of RNA Pol II. The 
phosphorylation state of the CTD (RNA Pol II0) enhances splicing by facilitating 
the binding of spliceosomes (Hocine et al., 2010). The interaction between 
the transcription machinery and the spliceosome suggests a link between the 
availability of the transcript exposed to the spliceosomes and the transcription 
rate. Abnormal transcription elongation rate affects the inclusion or exclusion of 
exons, many of which are found in tumors (Fong et al., 2014). Hence, an optimal 
process for transcription elongation is needed for appropriate pre-mRNA splicing. 
Before the mature mRNA reaches the cytoplasm for translation, it needs to be 
efficiently exported (Figure 1e). SR proteins are affiliated with the pre-mRNA 
during splicing and help to guide the mature mRNA into the cytoplasm further 
(Moore and Proudfoot, 2009). Furthermore, the THO/TREX complex is coupled 
with the mRNA co-transcriptionally, which facilitates efficient export (Sträßer et 
al., 2002). 
As discussed, transcription initiation, elongation, splicing, and export are tightly 
coupled together, where they collectively influence the outcome of transcription. 
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The inherited genetic information is not only deciphered into mRNA but is also 
escorted to the cytoplasm through various factors.
Figure 1
Sketch of eukaryotic transcription regulation. Inside the nucleus of eukaryotic cells, DNA is wrapped 
around histone molecules, which dictates the accessibility of DNA sequences to various transcription 
factors. Upon histone modifi cations (e.g., methylation, acetylation) depending on cellular context, the 
dynamics of chromatin structures altered, resulting in an active or inhibitory transcription state (a). In 
the case of active transcription, transcription factors scan for the binding platforms at the promoter 
regions of a gene (b), which eventually recruit RNA polymerase to initiate the process of transcription 
(c). Primary messenger RNA (mRNA) products are produced with both exons and introns. These 
immediate products are then spliced to remove the non-coding regions of introns, which could lead 
to alternative splicing, generating mRNA variants (d). Once the mature mRNA is manufactured within 
the nucleus, these molecules require effi  cient export into the cytoplasm for further translation into 
proteins (e). 
Nature’s selection for variations, epigenetics
As human beings, 99% of our genetic information is shared between us. Still, 
our appearances, physiological characteristics, and living habits vary signifi cantly 
depending on where we live, how we eat, and what we do. Interestingly, even twins 
with identical genetic background diff er in many aspects. Such diff erences have 
been explained in the study of epigenetics - a type of gene regulatory mechanism 
that functions without altering the DNA sequence. DNA methylation is one of 
the fi rst studied epigenetic regulations. Among all the diff erent biochemical 
modifi cations, cytosine is considered a dynamic nucleotide, which is frequently 
found methylated at the fi fth carbon (5mC). Such methylations exist primarily 
in the form of CpG dinucleotides, of which 60-80% are found methylated in the 
human genome (Lister et al., 2009). DNA-methyl transferases (DNMT) is the family 
of proteins that catalyze the process. The distribution of these CpG sequences 
is biased toward the promoter regions of coding genes. Studies have shown its 
essential role in the epigenetic regulation of development,  tumorigenesis, and 
genomic imprinting (Li et al., 1993; Linhart et al., 2007; Okano et al., 1999). 
As mentioned earlier, histone modifi cation is another fold of epigenetic regulation 
related to transcriptional output. Almost all forms of modifi cations are associated 
with transcription, suggesting the complex dynamics of transcription control via 
conformation changes of nucleosomes (Kouzarides, 2007). Furthermore, specifi c 
histone modifi cations are valuable markers for identifying functional DNA 
elements. For instance, H3K4me3 is associated with active transcribing promoter 
regions, while H3K4me1 and H3k27ac indicate typical enhancer elements (Calo 
and Wysocka, 2013). These modifi cations on DNA sequences shed light on how 
epigenetic information is coded in the nucleus.
Likewise, epigenetic regulation touches further into the cytoplasm in which the 
courier of the genetic information is interpreted. mRNA undergoes extensive 
regulations on its rate of synthesis and decay; however, in the last two decades, our 
knowledge about the RNA biology has expanded enormously. MicroRNA (miRNA) 
is a family of non-coding RNA of ~22 nucleotides long. In the nucleus, miRNA is 
transcribed by RNA Pol II, processed by RNase III proteins, Drosha and Dicer, where 
it is fi nally exported by Exportin 5. The short transcript works by targeting the 3’ 
untranslated region (UTR) of mRNA via its complementary sequence at the 5’ end 
(Bartel, 2009). Upon target recognition, miRNA is assembled into an RNA-induced 
silencing complex (RISC), inducing translation inhibition and mRNA decay (Ha and 
Kim, 2014). A single miRNA could target hundreds of putative mRNA strands, 
aff ecting their regular functions (Baek et al., 2008). 
Like DNA methylation, RNA also sustains diff erent biochemical modifi cations, 
including N6-methyladenosine (m6A), N1-methyladenosine (m1A), N6, 
2’-O-dimethyladenosine (m6Am), etc. As the most abundant RNA modifi cation, 
m6A can be found at every 700-800 nucleotides, accounting for 0.2-0.6% of 
all adenosines in mammalian RNA populations (Roundtree et al., 2017). The 
development of new methods allows transcriptome-wide quantifi cation of m6A 
content across diff erent organisms (Dominissini et al., 2012; Meyer et al., 2012), 
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and even at single nucleotide resolution (Linder et al., 2015). The biogenesis of 
m6A involves diff erent sets of proteins, including writers (METLL3/14, WTAP), 
erasers (FTO, ALKBH5), and readers (YTHDF1/2, HNRNPC). Interruptions of 
these key factors have been reported to infl uence the level of m6A and alter its 
cellular functions (Batista et al., 2014; Jia et al., 2011; Liu et al., 2014). Given the 
localization of m6A eff ectors in the nucleus and cytoplasm, the role of m6A has 
been widely researched. METTL3/14, FTO, WTAP are localized at nuclear speckles, 
and control alternative splicing (Ping et al., 2014; Zhao et al., 2014). Also, cellular 
mRNA stability could be regulated through m6A modifi cation via m6A reader-
assisted RNA decay (Wang et al., 2013; Wang et al., 2014). More recently, m6A 
profi ling indicates the enrichment of m6A modifi cations within exons and around 
stop codons (Dominissini et al., 2012), suggesting it could exhibit regulation on 
translation. m6A readers recognize both m6A in the 5’UTR and 3’UTR, promoting 
cap-independent and cap-dependent translation (Meyer et al., 2015; Wang et al., 
2015). Conversely, as discussed later in this thesis, we have identifi ed an inhibitory 
role of m6A on translational effi  ciency through coupled deposition of m6A with 
RNA Pol II (Slobodin et al., 2017). 
Emerging power of CRISPR-Cas9
The fi eld of gene editing has arisen in the past fi ve years, indicating a bright future 
for disease treatment, embryo adjustment, crop improvement, etc. Clustered 
Regularly Interspaced Short Palindromic Repeats (CRISPR), originated from a type 
of adaptive immune system used by bacteria against foreign viruses. It further 
incorporates DNA sequences from the invading organism into its own genome for 
a memorable immune response (Fineran and Charpentier, 2012; Wiedenheft et al., 
2012). The invading DNA is processed into the CRISPR repeat array and transcribed 
into CRISPR RNA (crRNA) as photospacer sequences, serving as a guide for the 
transactivating CRISPR RNA (tracrRNA) and Cas9 nuclease to cleave the target DNA 
(Deltcheva et al., 2011). To minimize self-cleavage of the integrated photospacer 
sequences, the cleavage only happens on the invading DNA through which the 
photospacer is next to a photospacer adjacent motif (PAM). In cells, cleavage of 
the DNA creates double-strand breaks, allowing error-prone DNA repairs (e.g., 
non-homologous end joining, NHEJ) to introduce deletions or insertions. As a 
result, this disrupts the coding sequences of the target gene (see also Figure 2). 
Signifi cant eff orts have been made to generate a simple toolbox for biological 
studies, resulting in a series of genome-wide genetic screen studies in human and 
mouse cells (Koike-Yusa et al., 2014; Shalem et al., 2014; Wang et al., 2014). 
Alternative applications have been developed to harness gene expression owing 
to the tight interaction of Cas9 nuclease on its target DNA. CRISPR interference 
(CRISPRi) was developed to s timulate or inhibit the transcription of a specifi c 
gene, using a modifi ed dead Cas9 (dCas9) that has already lost its nuclease 
activity. By tethering a transcription activator (e.g., VP64) or a suppressor (KRAB) 
to dCas9, researchers have successfully manipulated the transcriptional profi les of 
diff erent genes (Maeder et al., 2013; Mali et al., 2013; Qi et al., 2013). Furthermore, 
when fusing dCas9 with DNA methylation proteins (DNMT3A), researchers have 
successfully deposited methylation at the target loci and altered gene expression 
Figure 2
Schematic view of how CRISPR-Cas9 modifi es DNA sequences. A complex of crRNA, tracrRNA, and Cas9 
nuclease (upper panel in yellow, grey) is formed to search for the complementary sequences on the 
host genome (upper panel in blue). Once bound to the target sequence adjacent to the PAM sequence 
(upper panel in red), Cas9 cleaves three nucleotides upstream of the PAM sequence, causing double-
strand break. Mutations at the target loci are introduced via NHEJ, leading to deletions or insertions. 
(Amabile et al., 2016; Liu et al., 2016). Lastly, using CRISPR to target transcription 
factor-binding sites at enhancer elements, we have achieved programmable 
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enhancer control in human cells and identified novel regulatory elements during 
senescence (Han et al., 2018; Korkmaz et al., 2016). 
The complex life of AP1 
Activating protein 1 (AP1) was one of the first identified transcription factors, 
whose discovery widened our knowledge on how transcription factors activate 
the transcription of genes bearing AP1 binding sites, during cell proliferation and 
transformation (Angel and Karin, 1991). The AP1 family comprises several groups 
of dimeric proteins with structurally related leucine zipper domains: JUN, FOS, 
ATF and MAF family members(Shaulian and Karin, 2002). Functional DNA binding 
requires the dimerization of AP1 proteins. Although JUN proteins could form 
homo- and heterodimers, FOS proteins can only bind to JUN proteins to assemble 
a tight conformation (Hess, 2004). It has recently been suggested that AP1 could 
serve as co-factors in modulating chromatin dynamics. In macrophages, it binds to 
C/EBP factors to organize enhancer activities and dictate cell identities (Heinz et 
al., 2010); and in fibroblasts, AP1 plays a pivotal role in displacing nucleosomes, 
granting more accessibility to other TFs (Vierbuchen et al., 2017). Therefore, 
asides from promoting transcription at genes, the activities of AP1 at non-coding 
regions (e.g., enhancers) might reveal novel regulatory networks of the genome.
Cellular senescence
The phenotypes of senescence have been well-known for centuries. Humans 
have continuously witnessed the cycle of life and death. However, the scientific 
description of senescence was only proposed five decades ago by Hayflick and 
Moorhead (Hayflick and Moorhead, 1961). They discovered that non-tumorigenic 
cells cultured in vitro have a limited proliferation span, in contrast to the infinite 
proliferation of cancer cells. The emergence of cellular senescence is due to the 
shortening of the telomeres located at the end of each chromosome. Given the 
substantial interests in understanding the hidden mechanisms behind cellular 
senescence, extensive researche have uncovered a large part of the puzzle. 
Various stimuli activate p53, the guardian of cellular proliferation, and its 
downstream cyclin-dependent kinase inhibitors p16 (CDKN2A) and p21 (CDKN1A). 
Activation of the CDK inhibitors causes cell cycle arrest, together with a series 
of senescence markers. These include the degradation of the nuclear lamina, 
heterochromatinization of E2F targets, and senescence-associated secretory 
phenotype (SASP) (He and Sharpless, 2017). Once the stimuli persist, the cells 
eventually enter an irreversible growth arrest (Stein et al., 1999). Although the 
outcome of cellular senescence is similar to different stimuli, the responsible factors 
can vary. According to the different types of stimuli, cellular senescence has been 
grouped into multiple subtypes. 1) Replicative senescence refers to the condition 
of multiple cell division, resulting in reduced proliferation capacity (Hayflick, 1965; 
Hayflick and Moorhead, 1961). 2) DNA-damage induced senescence describes the 
situation in which the cells sense an overload of irreparable DNA damage, leading 
to the execution of cells by either senescence or apoptosis (Hernandez-Segura 
et al., 2018). 3) Oncogene-induced senescence (OIS) is a type of senescence 
with excessive activation of oncogenes (e.g., RAS, BRAF), normally adopted from 
genomic mutations (Sharpless and Sherr, 2015). 
The occurrence of OIS in vivo has been debated for years considering it was first 
discovered in vitro (Serrano et al., 1997). Some have found that mouse embryonic 
fibroblast cells (MEF) with ectopic expression of RAS become immortal instead of 
triggering OIS, which suggests that the overexpression of RAS was not adequate to 
initiate OIS in MEF (Trotman et al., 2003). In contrast, several studies proposed that 
mutations of different oncogenes (KRAS, BRAF) trigger OIS in human and mouse 
tumor models (Courtois-Cox et al., 2006; Michaloglou et al., 2005). The function 
of OIS during tumor development remains to be elucidated, yet it provides some 
insights on potential therapies. 
The scope of this thesis
This thesis explores multiple aspects of the transcription regulatory network 
with regards to human cells - From the initiation of transcription to the 
efficiency of translation. Chapter 2 attempts to establish a connection between 
the transcription and translation processes. By employing multiple in vitro 
experiments, a positive correlation between transcription and translation was 
first discovered, where it was solely controlled via transcription rate. The study 
leads to the identification of one of the first known functions of m6A at coding 
regions. While seemingly counterintuitive to the current recognition about m6A 
on translation, we augment the role of m6A on translation via the discovery of 
its co-transcriptional deposition.  Chapter 3 reviews the connection between the 
transcription steps of splicing, export, decay, and translation of mRNA, reinforcing 
the hypothesis that transcription is not an independent event, and is instead 
linked to the entire life cycle of mRNA. Chapter 4 investigates the functional role 
of AP1 in enhancer regions during OIS. The study results in the identification of 
a novel enhancer with an AP1 binding motif regulating senescence through its 
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target gene FOXF1. Although extensively characterized, AP1 and FOXF1 are not 
reported to act as regulators of senescence. A new trans-regulatory network of 
genes to counterbalance the effect of oncogene activation was uncovered. In 
Chapter 5, a general discussion about the current view of the field is conducted. 
Finally, some outlooks are raised to potentially generate a better understanding 
of transcriptional regulation. 
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Summary 
Transcription and translation are two main pillars of gene expression. Due to 
the different timings, spots of action and mechanisms of regulation, these 
processes are mainly regarded as distinct and generally uncoupled, despite 
serving a common purpose. Here we sought for a possible connection between 
transcription and translation. Employing an unbiased screen of multiple human 
promoters, we identified a positive effect of TATA box on translation and a general 
coupling between mRNA expression and translational efficacy. Using CRISPR-Cas9-
mediated approach, genome-wide analyses and in vitro experiments, we show that 
the rate of transcription regulates the efficacy of translation. Furthermore, we 
demonstrate that m6A modification of mRNAs is co-transcriptional and depends 
upon the dynamics of the transcribing RNAPII. Suboptimal transcription rates 
lead to elevated m6A content, which may result in reduced translation. This study 
uncovers a general and widespread link between transcription and translation that 
is governed by epigenetic modification of mRNAs.
Keywords
Transcription, translation efficacy, N6-adenosine methylation, m6A, TATA, RNAPII, 
gene regulation.
Introduction
Transcription of genome-encoded information into mRNA and translation of 
mRNA into a functional protein are the main layers of gene expression. Due to 
the existential need to adjust gene expression to both intracellular requirements 
and extracellular stimuli, both processes are subject to regulation at multiple 
levels. Transcription is a highly controlled process that is extensively regulated at 
the levels of initiation, elongation, and termination. Recent studies in eukaryotes 
linked transcription to other levels of mRNA regulation, such as alternative 
splicing (Dujardin et al., 2014), polyadenylation (Oktaba et al., 2015), localization 
and translation (Zid and O’Shea, 2014), and degradation (Dori-Bachash et al., 
2012). While splicing and polyadenylation are thought to be co-transcriptional, 
and therefore could be directly affected by the RNAPII dynamics, the effect on 
translation and degradation, which have distinct spatial and temporal dynamics, 
is more complicated to perceive. A recently formulated model explains the 
“imprinting” role of transcription by co-transcriptional recruitment of “coordinator” 
proteins (Haimovich et al., 2013), which accompany the synthesized transcript and 
are capable of regulating its future fate.
Translation of mRNAs is controlled mainly via initiation (Sonenberg and Hinnebusch, 
2009) and elongation (Richter and Coller, 2015). Although several recent studies 
suggested certain levels of dependency between transcription and translation 
(Elfakess and Dikstein, 2008, Harel-Sharvit et al., 2010, Tamarkin-Ben-Harush et al., 
2014, Zid and O’Shea, 2014), it is not very clear whether these are limited to certain 
subgroups of mRNAs or represent a general link. In general, transcription and 
translation are still regarded as mutually independent processes, characterized 
by different timings, cellular locations, functional complexes and mechanisms of 
action.
N6-methyladenosine (m6A) is considered to be one of the most abundant RNA 
modifications, detected in thousands of human transcripts (Dominissini et al., 
2012, Meyer et al., 2012). Several recent studies connected m6A to the regulation 
of splicing (Xiao et al., 2016), translation (Meyer et al., 2015, Wang et al., 2015) and 
degradation (Wang et al., 2014). Overall, a growing body of evidence suggests that 
m6A plays an important role in multiple levels of mRNA regulation.
In this study, we tested a hypothesis suggesting a direct flow of information from 
transcription to translation. Combining an unbiased screen for examination of 
the effect of human promoters on mRNA translation and genome-wide analyses, 
we identified a positive correlation between mRNA expression and translation 
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efficacy (TE) and found that rate of transcription positively affects TE. Moreover, 
we observed that transcriptional dynamics are reflected in the relative deposition 
of m6A on mRNAs that affects translation. This study establishes a general and 
robust link between transcription and translation of mRNAs, and provides a 
mechanistic insight regarding the way transcription epigenetically “imprints” 
mRNA molecules.
Results
A reporter vector system to examine transcription-translation relationship
To examine the relationship between transcription and translation, we set to 
determine the effect of different human promoters on the translation of a reporter 
gene (Renilla luciferase, Rluc). For this purpose, we defined promoters as 0.5-
2.5Kb long regions characterized by high H3K4Me3 and low H3K4Me1 epigenetic 
marks upstream of transcriptional start sites (TSSs), supported by RNA-seq data 
of MCF7 cells (Loayza-Puch et al., 2013). To make our screen versatile and diverse, 
we cloned promoters from genes connected to stress response, autophagy, ER 
metabolism, metastasis, as well as multiple transcription factors. While cloning the 
promoter sequences, we avoided regions extending downstream the respective 
TSSs as these might result in the inclusion of additional 5’ untranslated regions 
(5’UTRs) into the reporter transcripts, potentially complicating the interpretation 
of results. As each of the cloned promoters drives the expression of the same 
reporter gene, we affiliated every promoter to a unique 10-nt barcode (cloned in 
the 3’UTR of Rluc gene) to follow its expression in a pool of Rluc mRNAs (Figure 
S1A). Following these guidelines, we cloned 135 human promoters (Table S1) to 
create a library named Pro-Lib, where most of the promoters were associated with 
two or more different barcodes to provide higher experimental confidence. As 
expected, cloned promoter regions substantially induced Rluc expression (Figure 
S1B). For normalization of expression, Pro-Lib included an additional reporter gene, 
Firefly luciferase (Fluc) used as inner control (Figure S1A). Last, we employed FRT 
recombination system and used competent Flp-In MCF7 cells to stably integrate 
a single copy of a Pro-Lib vector per cell in the identical genetic locus in order to 
avoid any possible influence of different chromatin neighborhoods on the reporter 
gene expression.
After establishing the library in a stable population, we performed a polysomal 
profiling experiment using sucrose gradients, a classical method to separate 
mRNAs according to the amount of bound ribosomes. Since we examined only 
the barcoded Rluc mRNAs, their relative segregation in the gradient indicates 
ribosome density and translation efficiency (TE) estimation. We named the whole 
procedure barcoded polysomal profiling, or BPP (Figure 1A). Relative enrichment 
of Pro-Lib barcodes in the various fractions of the gradient showed that most Rluc 
mRNAs are localized in the initial polysomal fractions (i.e., 9-12; Figure 1B). Control 
total RNA segregation showed a characteristic pattern of polysomes and EDTA-
sensitivity, in line with the known dependence of polysomes on the availability of 
Mg2+ ions (Figures S1C and S1D). 
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Figure 1. A screen for examination of relationship between transcription and 
translation. 
(A) Schematics of the barcoded polysomal profiling (BPP) approach. (B) A typical segregation of Rluc 
mRNAs. (C) Control Rluc transcript with 5’TOP sequence exhibits rapid shift to non-translating fractions 
upon inhibition of mTORC1. (D) Control Rluc transcript shifts to denser fractions following splicing. The 
bar diagram below represents normalized relative Rluc protein expression assessed by luciferase assay 
in two separate clones. See also Figure S1.
Next, we tested whether BPP can detect changes in TE. For this purpose, we 
employed Rluc mRNA containing 5’-terminal oligopyrimidine tracts (5’TOP) derived 
from RPL37a gene. Translation of mRNAs possessing 5’TOP is highly dependent 
on mTOR activity, resulting in a rapid translational arrest following mTOR 
inhibition, compared to other mRNAs (Thoreen et al., 2012). Indeed, inhibition 
of mTORC1 resulted in a global moderate shift of the Rluc mRNAs to fractions 
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9-11 (e.g., SPTBN1 promoter), while a 5’TOP-containing transcript was depleted 
from the translated fractions of the gradient (Figure 1C). Interestingly, we also 
identifi ed several additional Rluc transcripts exhibiting similar hypersensitivity 
towards the inhibition of mTORC1 (Figure S1E). Further analysis of the sequences 
adjacent to their TSSs (Figure S1F) identifi ed stretches of pyrimidines that could 
serve as 5’TOP signals, providing a probable explanation for their dramatic 
response. To further test detection capabilities of BPP, we examined the eff ect 
of splicing on TE. Indeed, we observed that spliced Rluc mRNA shifts to heavier 
polysomal fractions and yields more protein (Figure 1D), as expected from the 
known positive eff ect of splicing on translation (Nott et al., 2004). Altogether, our 
control experiments demonstrate that BPP is capable of examining multiple Rluc
mRNAs in bulk and detecting changes in TE of individual transcripts. 
TATA box confers higher translational effi  cacy
Inspecting the segregation of the barcoded Rluc mRNAs on sucrose gradients, 
we identifi ed 12 promoters that caused a shift of the reporter transcript toward 
higher ribosomal occupancy fractions in at least two independent experiments. 
Intriguingly, four of these promoters contained a TATA-box element (Figure 
2A) and four others had TA-rich sequences that could potentially serve as non-
canonical TATA boxes (Figure S2A), indicating that this promoter element could 
positively infl uence translation. To test this possibility, we supplied several TATA-
less promoters with an artifi cial TATA element (consisting of the TATA sequence 
followed by the short downstream sequence derived from human ACTB gene). 
In all cases, this manipulation resulted in Rluc transcripts occupying denser 
fractions of the gradient (i.e., 11-13; Figures 2B and S2B), supporting the previous 
observations. Taking the ASNSD1 promoter as a model, we observed a positive 
eff ect of TATA addition on TE under various conditions (Figure S2C), thus indicating 
a robust phenomenon. 
Since artifi cial introduction of TATA may alter the TSS, possibly impacting 
translational capacity (Rojas-Duran and Gilbert, 2012), we investigated in details 
the 5’UTRs produced from the TATA-containing and TATA-less promoter pairs. 
By northern blotting we observed that most of the tested promoters resulted in 
reporter transcripts of a similar length, with a noticeable enhancement of mRNA 
levels in TATA-containing promoters (Figure 2C). To establish precisely the 5’-ends 
of the transcripts, we performed 5’RACE analyses, which showed a very narrow 
peak ~25nt downstream the inserted TATA element (Figure S3A,B). To test whether 
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Figure 2. Presence of the TATA element in promoters enhances TE. 
(A) Pro-Lib vectors encoding for TATA-containing promoters result in Rluc mRNAs shifted to the 
denser fractions of the gradient compared to other transcripts (e.g., under SPTBN1 promoter). 
(B) Pro-Lib vectors supplied with an artifi cial TATA yield Rluc mRNAs that are shifted to the denser 
fractions of the gradient compared to the parental TATA-less promoters. (C) Northern blot analysis 
of Rluc mRNAs; quantifi cation refl ects relative Rluc/Fluc ratio. (D) Relative levels of Rluc mRNAs and 
proteins produced by promoters with or without TATA element; note the super-induction of the protein 
expression. Data are represented as mean±SEM, n=4. (E) Relative levels of Rluc mRNAs and proteins 
produced by SV40 promoter upon mutagenesis of TATA; data are represented as mean±SEM, n=3. 
(F) Mutagenesis of SV40 promoter-derived TATA results in less effi  cient translation of Rluc mRNA as 
detected by BPP; data are represented as mean±SEM of a representative gradient, n=2. (G) Schematics 
of the CRISPR-Cas9-mediated mutagenesis of the endogenous TATA (in pink square) of c-Myc gene. 
Below: characterization of the diff erent c-Myc alleles of one of the isolated clones, including relative 
abundances. (H) Mutagenesis of the c-Myc TATA results in lowered mRNA levels (left chart) and further 
reduced c-Myc activity (right chart); data are represented as mean±SEM of n=3. (I) Western blot analysis 
of c-Myc protein in the TATA-mutated clone and wt MCF7 cells; see Figure S2I for the uncropped blot. 
(J) Polysomal profi lings of c-Myc mRNAs isolated from the clone with mutated TATA and wt MCF7 cells; 
data are represented as mean±SEM of a characteristic gradient; n=3. See also Figure S2G-K for the 
characterization of an additional clone.
these alterations in the 5’UTRs could explain the observed changes in translation, 
we in vitro synthesized Rluc transcripts bearing the diff erent 5’UTRs and examined 
their relative TE (Figure S3C). As the 5’UTR generated after the insertion of TATA 
sequence did not confer higher TE, we conclude that the observed positive eff ect 
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of TATA on translation is unlikely to stem from the differences in the 5’UTRs of Rluc 
mRNAs. 
So far we inferred TE from ribosome occupancy measurements reflected by 
migration within sucrose gradients. Next, we tested TE changes by measuring 
separately the levels of the reporter mRNA and protein in the promoter pairs. As 
expected, we observed significantly more mRNA produced from TATA-containing 
promoters (7-9 folds, Figure 2D), consistent with the levels measured by northern 
blotting (Figure 2C). In contrast, the increase in the level of protein activity was 
significantly higher (>20 folds), supporting the connection between the presence 
of TATA in promoter and enhanced protein production. To further test the role 
of the TATA element in translation, we mutagenized it within the SV40 promoter. 
Remarkably, loss of TATA reduced the reporter mRNA expression by ~14-fold and 
protein activity by ~80-folds (Figure 2E), suggesting reduced TE. Indeed, mRNA 
produced by a TATA-mutated promoter was enriched in the lighter polysomal 
fractions (Figure 2F), further supporting this indication. We observed similar 
results upon mutagenesis of TATA in other promoters (Figure S2D,E), suggesting 
that this effect is not restricted to any particular promoter.
Next we tested whether the positive effect of TATA on TE applies also to the 
endogenous mammalian gene expression. For this purpose, we chose c-Myc, a 
ubiquitously expressed gene with a single active TATA-positive promoter in MCF7 
cells (Figure S2F) and used CRISPR-Cas9 system to alter its TATA sequence (Figure 
2G). This strategy yielded isolated cell clones with disrupted c-Myc TATA on most of 
their alleles (Figure 2G and Figure S2G). Examination of c-Myc expression in these 
clones revealed a reduction of ~25% in c-Myc mRNA and ~50% in both protein 
activity and expression (Figure 2H,I and S2I,J). Moreover, polysomal profiling of 
c-Myc transcripts showed reduced ribosomal occupancy upon mutating the TATA 
element (Figure 2J and S2H), while a control transcript displayed very similar 
profiles in both clones (Figure S2K), indicating a c-Myc–specific effect. Thus, we 
conclude that the presence of the TATA element in a promoter enhances the 
efficiency of mRNA translation and note the validity of this observation to multiple 
promoters and genes. 
General association, but not causal link, between mRNA levels 
and translational efficiency 
In all the cases we studied, presence of TATA in a promoter stimulated both 
mRNA expression levels and TE. To examine if TE positively correlates with mRNA 
expression levels, we clustered the Pro-Lib BPP data to separate the transcripts of 
our library into two relative groups: one with lower TE (Figure S4A,B) and another 
with higher TE (Figure S4C,D), and compared the expression levels between 
these two groups. Indeed, we found that transcripts with higher TE tend to be 
more abundant (Figure 3A). To test whether this coupling is TATA-dependent, 
we repeated this analysis while omitting the promoters with artificially added 
TATA elements. Notably, this analysis yielded similar albeit less significant results 
(Figure 3B), thus suggesting a positive correlation between the abundance of 
Rluc transcripts and their TE, with no dependency on TATA. To further test this 
observation, we employed cells expressing an inducible version of the barcoded 
reporter gene (TRex-Rluc), in which the levels of Rluc mRNA are stimulated 
~17-fold after induction (Figure 3C). Importantly, induction of this gene yielded 
a significantly greater enhancement of protein activity (~60-fold, Figure 3C), 
suggesting translation boost. Indeed, subsequent BPP analysis revealed a strong 
increase in the ribosome occupancy of the induced reporter mRNA (Figure 3D and 
Figure S5A), supporting the notion that increased expression results in higher TE. 
Notably, we performed 5’RACE analysis of both induced and non-induced TRex-
Rluc mRNAs and found the scattering of TSSs to be very similar (Figure S3D). 
Altogether, we conclude that the observed link between the expression levels of 
mRNAs and their TE is not restricted to the TATA element and might therefore 
represent a more general phenomenon. 
To test if genome-wide data support global relationship between mRNA level 
and TE, we analyzed pairs of RNA-seq and Ribo-seq (ribosomal footprinting) 
datasets from multiple human cell lines. Intriguingly, we observed a positive 
global correlation between mRNA expression level and TE, which was rather weak 
but consistent and statistically significant (Figure 3E). Moreover, this correlation 
between mRNA levels and TE was also apparent in various stress conditions (Figure 
S5B,C). These results indicate that also in mammalian genomes, there is a positive 
correlation between expression levels of mRNAs and their TE.
To examine if mRNA levels could directly regulate TE, we transfected different 
amounts of in-vitro transcribed and purified Rluc mRNA into MCF7 cells and 
monitored the activity of the produced Rluc protein. We anticipated that if levels 
of mRNA positively stimulated TE, transfecting increasing amounts of 
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Figure 3. Levels of mRNAs positively correlate with TE but do not dictate it. 
(A) Reporter mRNAs from the Pro-Lib screen were separated into groups with relatively high or low 
TE (derived from the polysomal profi les, see Figure S4) and compared with their expression levels 
(estimated from read counts observed for each vector over all fractions). p-values calculated using 
Wilcoxon’s test. (B) Same comparison as described in (A) was performed after exclusion of mRNAs 
transcribed from promoters with artifi cial TATA element. (C) Levels of mRNA and protein resulting from 
the induced TRex-Rluc gene were measured and plotted relatively to the non-induced condition; data 
are represented as mean±SEM of n=3. (D) BPP examination of either induced or non-induced TRex-Rluc 
mRNAs; data are represented as mean±SEM of a characteristic gradient; n>5, see also Figure S5A. (E) 
Upper panels: paired RNA-seq and Ribo-seq datasets from diff erent human cell lines were examined 
for relationship between mRNA expression level and TE (calculated as the (log2) ratio between 
densities of ribosome footprint and RNA-seq reads). Lower panels: comparisons between the 10% of 
genes with lowest and highest expression levels are presented; p-values calculated using Wilcoxon’s 
test. (F) MCF7 cells were transfected with fold-wise amounts of in vitro transcribed (using HeLa nuclear 
extract) Rluc mRNA followed by measurement of RLuc activity after 18 hours; data are represented as 
mean±SEM of n=3. (G) Levels of Rluc mRNA and protein were compared between two populations of 
MCF7 cells expressing near single or multiple integrated copies of Lenti-Rluc unit. Data are represented 
as mean±SEM of n=3. (H) BPP analysis of Rluc transcripts described in (G); data are represented as 
mean±SEM of a characteristic gradient, n=3.
mRNA would result in an exponential increase of protein production. However, 
we observed a clear linear dependency between the two parameters (Figure 3F), 
suggesting indiff erence of the protein production rates to mRNA abundance. To 
test this conclusion further, we employed lentiviral-mediated stable integration 
of a transcriptional unit including promoter and Rluc gene and generated two 
stable populations with either nearly single or multiple integrations of the same 
transcriptional unit per cell, resulting in ~9-fold diff erence in Rluc mRNA levels 
(Figure 3G). Also here, increase in protein activity was similar to the increase in 
mRNA levels, indicating comparable TEs. Supporting this conclusion, Rluc mRNAs 
derived from both cell populations exhibited similar segregation patterns in 
sucrose gradients (Figure 3H). Altogether, these results suggest that while mRNA 
expression levels positively correlate with TE in multiple cellular models, mRNA 
abundance does not directly regulate it.
Rate of transcription positively aff ects translation effi  ciency 
Next we searched for the causal origin of the observed correlation between 
mRNA levels and TE. We considered the rate of transcription to be the most likely 
candidate since it directly regulates the expression levels of mRNAs. To test this 
possibility, we correlated transcription rates (as estimated by Genome Run-On 
sequencing, GRO-seq, (Core et al., 2008)) and TE (as determined by Ribo-seq and 
RNA-seq data) in BJ and MCF7 cell lines. In both cell types we observed a signifi cant 
positive association between the rates of transcription and TE of genes that do not 
possess upstream ORFs (Figure 4A and Figure S6A,B). This correlation is notable 
as this analysis integrates distinct datasets independently obtained from three 
genomic techniques in two diff erent cellular systems. 
To further investigate the relationship between rates of transcription and TE, we 
employed Camptothecin (CPT), a chemical compound that inhibits topoisomerase 
I and, in mild concentrations, slows down the progression of transcribing RNA 
polymerase II (RNAPII) (Dujardin et al., 2014). Indeed, when CPT was applied in 
parallel to the induction of TRex-Rluc gene, we observed a reduction of ~60% of 
Rluc mRNA, but a more prominent reduction of Rluc activity of ~80% (Figure 4B). 
This diff erence could be explained by the reduced ribosome occupancy, as refl ected 
by polysomal profi ling analyses (Figure 4C and Figure S5D). Thus, impediment of 
RNAPII progression does not only reduce the transcriptional rate of TRex-Rluc 
gene but also attenuates its TE. To further test the role of RNAPII dynamics on 
translation, we assessed TE of multiple genes in CPT-treated cells. Overall, CPT 
treatment resulted in TE reduction of 691 genes by more than 1.5-fold in two 
independent experiments (Table S2). As highly transcribed genes showed higher 
TE (Figure 4A), we speculated that CPT treatment would cause more pronounced 
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Figure 4. TE is affected by the rate of transcription.
(A) Upper panels: positive genome-wide correlations between translational efficacies and rates of 
transcription in BJ and MCF7 cells. Lower panels: direct comparisons between 10% of genes with 
lowest and highest transcription rates. GRO-seq data were from (Korkmaz et al., 2016, Leveille et 
al., 2015); Ribo-seq and RNA-seq data were from (Loayza-Puch et al., 2013); p-values were calculated 
using Wilcoxon’s test. B. Expression levels of Rluc mRNA and protein were examined following parallel 
induction of the TRex-Rluc gene and CPT treatment for 7 hours; data are represented as mean±SEM 
of n=3. C. Lysates of the two populations described in (B) were subjected to BPP procedure; data are 
represented as mean±SEM of a characteristic gradient, see also Figure S5D; n=3. D. Upper panels: 
genome-wide correlations between rates of transcription and TE changes after treatment with CPT. 
Lower panels: direct comparison of the effect on TE between the 10% of most highly and lowly 
transcribed genes; p-values were calculated using Wilcoxon’s test. E. Polysomal profilings of mRNAs 
after CPT treatment (red) show reduced TE compared to untreated cells (green). Columns represent 
the relative mRNA levels as detected by qRT-PCR; ALG8 was used as a control gene. Data are presented 
as mean±SEM of three technical measurements of a characteristic graident; n=3. See also Figure S6C. F. 
Cells with barcoded TRex-IRES-Rluc cassette (schematics) were induced for 18 hours and subjected for 
examination of Rluc mRNA and protein levels relative to the non-induced cells; data are presented as 
mean±SEM of n=3. G. Same cells as in (F) were treated in a similar way and subjected to BPP procedure. 
Data are presented as mean±SEM of three measurements of a characteristic gradient; n=3. H. Pro-
Lib vectors with SZT2 promoters, with or without the TATA element, were supplemented with IRES-
encoding sequence as shown on the schematics. Cells expressing these constructs were subjected to 
quantification of mRNA and protein levels; data are presented as mean±SEM of n=3. 
repressive effect on the translation of these genes. Indeed, intersection with GRO-
seq data demonstrated that impediment of RNAPII caused a significant reduction 
in TE of genes with relatively high transcription rate (Figure 4D). We further 
examined the polysomal segregation of several mRNAs, suggested by the genome-
wide experiments, and validated that these mRNAs indeed displayed reduced TE 
coupled with reduced expression, compared to ALG8 control mRNA (Figure 4E). 
To eliminate the possibility that the transcripts exhibiting translational shifts are 
truncated due to the CPT treatment, we re-examined these and other mRNAs 
using primers annealing to 3’UTRs only. Also in this case, the shift of mRNAs was 
apparent (Figure S6C). Taken together, we conclude that transcription rate is an 
important positive determinant of translation efficiency. 
Transcription-dependent translation regulation requires 
canonical translation initiation 
To further examine the mechanism by which transcription affects TE, we 
introduced an internal ribosome entry site (IRES) sequence into the inducible 
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TRex-Rluc cassette (TRex-IRES-Rluc gene, see schematics in Figure 4F) to bypass 
the canonical 5’cap-mediated initiation of translation. Interestingly, induction of 
TRex-IRES-Rluc gene resulted in Rluc activity that mirrored the changes in the 
mRNA levels (i.e.,~12-15 fold induction at both levels, Figure 4F), which contrasted 
the previously observed induction of the Rluc protein activity (>60-fold, Figure 
3C). Moreover, BPP analyses revealed similar segregation of both induced and 
non-induced IRES-Rluc mRNAs (Figure 4G), further suggesting lack of translational 
induction. Furthermore, introduction of IRES into constructs containing the 
artifi cial TATA element (e.g., SZT2 promoter) abolished the previously observed 
enhancement of TE (Figure 4H, compare with Figure 2D) and resembled the eff ect 
of TATA mutagenesis (Figure S2D). Thus, we conclude that canonical translation 
initiation is required for transcription-dependent enhancement of translation. 
m6A modifi cation mediates transcription-responsive translation 
Next we looked for a molecular event that could explain the link between 
transcription and translation. Since changes in transcription aff ected translation 
of multiple genes (Table S2), we reasoned that this molecular event should be 
robust and widespread. N6-methyladenosine (m6A) is an abundant nuclear dynamic 
mRNA modifi cation identifi ed in thousands of human transcripts (Dominissini et 
al., 2012, Meyer et al., 2012), recently implicated in translational regulation (Wang 
et al., 2015). Therefore, we asked whether m6A could bridge transcription and 
translation. 
First, we examined whether m6A levels could be aff ected by diff erent rates of 
transcription. We therefore performed immuno-precipitations of m6A-modifi ed 
RNAs (MeRIP) from cells with either induced or non-induced TRex-Rluc gene, and 
compared the relative recoveries of the diff erent Rluc transcripts. Strikingly, we 
observed very signifi cant diff erences between the two Rluc populations; the non-
induced mRNA was isolated much more effi  ciently in all tested mRNA regions 
(Figure 5A). Importantly, a control mRNA (AHNAK) showed similar recovery in both 
samples, suggesting a specifi c enrichment of the non-induced Rluc transcripts 
by MeRIP. We also assessed the methylation levels of Rluc mRNAs of the two 
populations expressing diff erent copy number of Lenti-Rluc gene (Figure 3G) and 
found them to be very similar (Figure S6D), suggesting that the diff erences observed 
in MeRIP are unlikely to stem from unequal mRNA expression levels. Furthermore, 
we observed diff erences in the post-MeRIP recovery of Rluc mRNAs transcribed 
from either TATA-containing or TATA-less promoters (Figure S6E), suggesting 
that promoters with intact TATA elements yield mRNAs with relatively lower m6A 
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Figure 5. Enhancement of m6A modifi cation of mRNAs upon attenuated transcription. 
(A) Cells bearing the TRex-Rluc gene were induced for 18 hours and subjected to the MeRIP procedure, 
together with untreated cells. Recovery effi  ciencies of regions spanning the Rluc mRNA were 
examined, normalized to the input levels and compared; AHNAK was used as a control methylated 
mRNA. Data are represented as mean±SEM of n=3. (B) Rluc mRNAs were transcribed in vitro using HeLa 
extract as detailed, resolved on agarose gels and quantifi ed (left chart, n=3) and further subjected 
to the relative comparison of their m6A contents (right chart, n=2). (C) Total RNA isolated from MCF7 
cells treated with CPT for 5 hours was enriched for polyA+ population and quantifi ed (left chart, n=3) 
and further subjected to the relative comparison of their m6A contents (right chart, n=3). (D) mRNAs 
presented in Figure 4E were tested for recovery after MeRIP procedure (striped columns) relatively to 
their RNA levels (plain columns) using qRT-PCR. Data are represented as mean±SEM of n=2. See also 
Figure S6D,E. (E) Relative levels of polyA+ RNA populations (plain columns) in cells expressing diff erent 
RNAPII mutants, and their relative m6A levels (striped columns) were examined; n=2. (F) MCF7 cells 
were treated for 5 hours and subjected to immuno-precipitation of RNAPII, followed by detection of 
METTL3 protein using Western blot. A characteristic blot is presented, n=4.
content. Next, we in-vitro transcribed Rluc gene in m6A-compatible nuclear HeLa 
extract (Shimba et al., 1995) using conditions that reduce rate of transcription (e.g., 
elevated MgCl2 (Wildeman et al., 1984), or a template with mutated TATA box), and 
tested the diff erent transcripts for m6A content. Indeed, both changes resulted 
in the relatively lower levels of Rluc mRNA, which were associated with higher 
deposition of m6A (Figure 5B). Importantly, both the UTRs and polyA tails of the 
diff erent transcripts were similar (Figure S3E,F). Furthermore, treatment with CPT 
reduced mRNA levels in parallel to the relative enhancement of their m6A content 
(Figure 5C), suggesting a negative correlation between transcription elongation 
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and m6A deposition. Additionally, we performed MeRIP analysis of genes that 
exhibited reduction of both mRNA levels and TE after CPT treatment (Figure 4E). 
These genes indeed displayed lower levels of mRNA coupled with enhanced m6A 
content (Figure 5D). To further address the link between the rate of transcription 
and m6A deposition in an additional independent system, we interrogated 
a-amanitin resistant RNAPII mutants exhibiting either normal (N792D) or slow 
(C4/R749H) rates of elongation (Fong et al., 2014). Similarly to the previous 
observations, we found that cells expressing the “slow” RNAPII mutant contained 
relatively lower levels of mRNA, associated with elevated methylation content 
(Figure 5E). Thus, various experimental approaches indicate that suboptimal rate 
of transcription results in higher m6A deposition on mRNAs. 
This conclusion raised the possibility that m6A modification of mRNAs occurs co-
transcriptionally and therefore we anticipated a physical interaction between 
RNAPII and the methyltransferase complex (MTC). To test this, we immuno-
precipitated RNAPII from either normally growing cells or following CPT treatment 
and probed the eluate for METTL3, a catalytic core of MTC (Wang et al., 2016). 
Remarkably, while in untreated conditions we observed no visible interaction, upon 
CPT treatment, METTL3 was efficiently co-precipitated (Figure 5F), suggesting co-
transcriptional m6A modification and enhancement of the interaction between 
RNAPII and MTC upon impediment of RNAPII elongation dynamics.
Next, we tested whether elevated levels of m6A could negatively affect translation. 
We first examined the translation capacity of the in vitro transcribed Rluc mRNAs 
in the conditions of reduced transcription and enhanced m6A (as presented in 
Figure 5B). In line with our hypothesis, conditions associated with attenuated 
transcription resulted in lower efficacy of protein production compared with the 
normal transcription conditions (Figure 6A). Next, we examined the global effects of 
CPT treatment and expression of the “slow” RNAPII mutant on polysomes. Figures 
6B,C show that these two treatments considerably reduced the RNA content of the 
polysomal fractions, suggesting a general reduction of translation and providing 
further evidence for the positive feedback between transcription and translation.
To directly examine the role of m6A in translation, we knocked-down two genes in 
the m6A pathway (METTL14 and YTFDH1, Figure S6F) and examined the effect on 
the expression of Rluc mRNA. Interestingly, knocking down either factor resulted 
in a significant boost in the expression of the non-induced Rluc, while the effect on 
the induced gene was moderate (Figure 6D). Importantly, while global polysome 
segregation analysis indicated only a slight effect of each knockdown on 
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Figure 6. Effect of the m6A modifications on translation. 
(A) Rluc mRNAs were transcribed invitro using HeLa extract in the indicated conditions, and transfected 
into MCF7 cells in fold-wise amounts; RLuc enzymatic activity was measured after 24 hours. The trend 
lines are represented by the dashed lines; n=3. (B) MCF7 cells were treated with CPT for 5 hours and 
subjected to polysomal profiling with subsequent measurement of the average levels of total RNA in 
the collected fractions. Data are presented as mean±SEM, n=3. (C) Polysomal segregation of total RNA
from cells expressing “normal speed” or “slow” RNAPII; data are presented as mean±SEM of n=3. 
See also Figure S6H. (D) TRex-Rluc gene was induced for 18 hours in MCF7 cells transfected with 
the detailed siRNAs, or left uninduced. Expression levels of RLuc protein were assessed; data are 
represented as mean±SEM of n=3. (E) Cells bearing the TRex-Rluc gene were transfected with the 
indicated siRNAs, grown for 56 hours and subjected to BPP. Upper panel: non-induced Rluc; lower panel: 
Rluc expression was induced for 24 hours prior to harvesting; data are represented as mean±SEM of 
three measurements of a characteristic gradient; n=3. (F) Results of the MeRIP experiment presented 
in Figure 5A were normalized to calculate the total relative recovery of Rluc mRNAs by the different 
regions. Error bars represent mean±SEM of n=3. (G) Rluc mRNAs were in vitro transcribed using T7 
polymerase in the presence of the indicated proportions of m6A nucleoside and in vitro translated 
using indicated amounts of mRNA as input. Data are represented as mean±SEM of n=4. (H) Model of the 
transcription-dependent regulation of TE. Slow or paused RNAPII results in the enhanced interaction 
with MTC (step 1), which leads to enhanced deposition of m6A on mRNAs (step 2), negatively affecting 
translation efficiency (step 3).
general translation (Figure S6G), possibly due to compensatory mechanisms, BPP 
assay verified a considerable increase in the TE of the non-induced Rluc mRNA in 
these conditions (Figure 6E). Since methylation of coding regions (CDRs) has been 
recently suggested to attenuate translation (Choi et al., 2016), we re-examined 
the experiment presented in Figure 5A, in order to compare the relative changes 
in methylation of the different Rluc transcript regions. Remarkably, the highest 
gain of methylation upon transcriptional attenuation was observed throughout 
the CDR of Rluc (up to ~11% near the end of the non-induced mRNA CDS), whereas 
both UTRs (i.e., 5’ and 3’) displayed the lowest levels (<1%, Figure 6F). This result 
therefore suggests a plausible explanation for the strong inhibitory effect of 
transcriptional repression on TE that we observed (Figure 3D). Lastly, we sought to 
directly examine the effect of m6A levels on protein production, and produced Rluc 
mRNAs in vitro with different proportions of methylated adenosines. Strikingly, 
increased incorporation of m6A led to a progressive attenuation of TE of the 
Rluc (Figure 6H), suggesting an overall inhibitory effect of m6A modification on 
translation. Altogether, these results demonstrate that covalent m6A modification 
of mRNAs depends on the dynamics of the transcribing RNAPII, and tends to 
negatively affect translation efficacy. Therefore, we conclude that m6A links 
transcription and translation.
Discussion 
In this study, we describe a direct and general flow of information from transcription 
to translation in human cells. We show that genes possessing strong transcriptional 
activity give rise to mRNAs with greater capacity to produce proteins. We propose 
that this link is mediated, at least in part, by the co-transcriptional N6-methylation 
of adenosines in mRNA - the m6A modification. Suboptimal transcription results 
in a relatively higher m6A content of transcripts and this, in turn, tend to reduce 
translation efficacy (Figure 6H). 
Initially, we employed Pro-Lib, a library consisting of multiple human promoters 
that drive the transcription of a single reporter Rluc gene, and combined it with 
barcoded polysomal profiling procedure to examine translation efficacy (TE) 
of the reporter mRNAs. This approach allowed for several advantages. First, 
recombination-mediated single-copy genomic integration resulted in a balanced 
expression of the reporter constructs. Second, all vectors were integrated 
into the same genetic locus, minimizing the probability of an artificial effect of 
chromatin neighborhood on transcription. Third, establishing a pooled stable 
reporter population simplified the maintenance and treatments and increased 
experimental accuracy. Lastly, deep sequencing of the barcodes enabled a 
quantitative coverage of nearly all reporter transcripts in the polysomal fractions 
within a single experiment. 
Using Pro-Lib, we observed that promoters possessing either confirmed or 
suspected TATA-box element (TATA) yield transcripts characterized by a higher 
capacity to accommodate ribosomes and produce proteins. This indicated that 
the presence of this element in a promoter not only boosts transcription, but 
also enhances mRNA translation, suggesting a positive effect of TATA box 
promoter element on TE. TATA elements activate transcription (Xiao et al., 1995), 
and a recent genome-wide bioinformatics analysis suggested that mammalian 
genes possessing TATA in their promoter tend to be translated more efficiently 
(Tamarkin-Ben-Harush et al., 2014), which was attributed to their characteristics 
(e.g., gene length, probability of upstream ORF, etc.). In this study, we support 
these observations and conclude, in addition, that a mere presence of intact TATA 
element in a promoter potentiates mRNA translation (Figures 2B, S2A). 
The TATA element activates transcription (Xiao et al., 1995), resulting in elevated 
levels of mRNA. Indeed, we identified a strong correlation between mRNA levels 
and translation in the Pro-Lib screen and further showed that this link is not unique 
to TATA, holding true for the global mammalian gene expression. We note that 
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the correlations between mRNA levels and TE are rather weak, probably reflecting 
multiple additional levels of regulation, but statistically significant. Interestingly, 
this correlation was noticed in both animal cells and yeast (Schwanhausser et 
al., 2011, Weinberg et al., 2016), likely indicating an evolutionarily conserved 
phenomenon. Importantly, while mRNA levels could be linked to TE via mechanisms 
that couple mRNA stability and translation (Radhakrishnan et al., 2016), we 
found that mRNA levels per se do not directly affect translation (Figures 3F-H). 
Instead, we observed a global positive effect of transcription on TE. Impediment 
of transcription either via CPT treatment or in the in vitro assays, demonstrated a 
role for transcriptional elongation in the determination of translational efficacy. 
As transcription initiation and elongation are related processes (Marbach-Bar 
et al., 2013), future studies are necessary in order to precisely appreciate the 
role of transcription initiation in the regulation of translation. Regarding mRNA 
translation, our observations suggest its responsiveness to transcriptional 
changes only when the initiation of translation involves 5’cap. When this canonical 
initiation was bypassed by the introduction of IRES, the translation machinery 
failed to respond to transcriptional fluctuations (Figures 4F-H), indicating that this 
initial step, which is considered to be rate limiting and highly controlled, might 
exert additional aspects of translational regulation.   
Here we suggest that m6A, at least partially, mediates the communication between 
transcription and translation. Our results indicate that attenuated transcription 
leads to enhanced methylation of mRNAs. We present here biochemical evidence 
for a physical interaction between METTL3 enzymatic subunit of the methylation 
complex (MTC) and retarded RNAPII (Figure 5F). These results suggest that m6A 
modification is, at least in part, co-transcriptional and indicate that the affinity 
between MTC and RNAPII depends upon the dynamics of the latter. While it remains 
unclear how exactly this interaction is induced, we propose that slow progression 
or frequent pausing of RNAPII increase the probability of MTC engagement. The 
global enrichment of modified nucleotides at the start of mRNAs and around STOP 
codons (Meyer et al., 2012, Dominissini et al., 2012) supports this hypothesis, as 
these are the locations of probable RNAPII pausing (Jonkers and Lis, 2015). Since 
a considerable proportion of genes experience slow or paused transcription (Core 
et al., 2008), it would be important to examine, in future studies, whether these 
genes are preferentially methylated. We note that together with m6A, additional 
factors might bridge transcription and translation, e.g., (Rojas-Duran and Gilbert, 
2012, Tamarkin-Ben-Harush et al., 2017).
Globally, we observed that enhanced mRNA methylation results in lower 
translation capacity. Interestingly, several recent studies indeed linked m6A to 
translation, but reported mainly a stimulatory role of this modification (Meyer et 
al., 2015, Wang et al., 2015, Zhou et al., 2015). We anticipate that the precise effect 
of m6A on translation depends on the location of the modified nucleotide within 
the transcript. Remarkably, most of the mentioned studies observed enhanced 
methylation within UTRs of transcripts. In contrast, methylation within CDRs 
reduced translation (Qi et al., 2016), probably due to the attenuated elongation 
(Hoernes et al., 2016, Choi et al., 2016). Given that most of the methylated residues 
are located within CDRs, we would anticipate an overall negative effect of m6A 
methylation on translation, which we indeed observed upon random incorporation 
of modified adenosines (Figure 6G). 
Our study suggests that m6A modification of mRNAs is co-transcriptional and is 
used to epigenetically imprint mRNAs and control their future activity and fate. 
This way the dynamics of the transcription process could be “recorded” in the 
methylation profile of a given mRNA, which, in turn, could further impact multiple 
steps of mRNA biology. 
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STAR Methods
CONTACT FOR REAGENT AND RESOURCE SHARING 
Further information and requests for resources and reagents should be directed 
to and will be fulfilled by the Lead Contact, Reuven Agami (r.agami@nki.nl). 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Human breast adenocarcinoma MCF7 cells (female) were purchased from ATCC 
and authenticated by detecting the deficiency of caspase-3 using Western blotting. 
These cells were grown in DMEM media (Gibco) supplemented with 10% bovine 
serum and penicillin/streptomycin (Gibco) in 5%CO2-buffered incubators at 37°C. 
Cells were split twice per week and kept in culture for up to 8 weeks. To create 
cells compatible with FLP recombination system (ThermoFisher scientific), MCF7 
cells were transfected with the pFRT/lacZeo and grown in the presence of Zeocin 
(400µg/ml) until stable colonies appeared. These cells were named MCF7/FRT and 
used for integration of Pro-Lib. To integrate Pro-Lib, these cells were transfected 
with Pro-Lib vectors along with pOG44 vector (ThermoFisher scientific) in quantities 
of 1.6µg+3µg respectively, per 35-mm well. After 48h, the cells were collected, 
re-plated onto 10-cm dishes, and selected for three weeks in the presence of 
Hygromycin (0.1 mg/ml f.c.). After appearance of the stable colonies, the cells were 
collected, frozen and used for further experiments. To create cells compatible 
with T-REx™ inducible system (Invitrogen), MCF7/FRT cells were transfected with 
pcDNA6/TR vector encoding for the tetracycline-sensitive repressor and separate 
clones were selected for their resistance to Blasticidin S (5mg/ml). The induction 
efficiency was examined in separate clones by transient transfection with pcDNA4/
TO-Rluc construct, incubation with Doxycycline (Sigma, 1mg/ml final conc.) for 17 
hours and measurement of Renilla protein activity. One suitable clone was chosen 
for further experiments and the cells were named MCF7/FRT/TR. These cells were 
stably transfected with pcDNA5/FRT/TO plasmid encoding for barcoded Renilla 
ORF (TRex-Rluc) in the presence of pOG44 vector (ThermoFisher scientific) and 
grown for three weeks in the presence of Hygromycin (0.1 mg/ml f.c.). Individual 
colonies were isolated and tested by treatment with Doxycycline (Sigma, 1mg/
ml final conc.). 293 cells bearing integrated alpha-amanitin resistant mutants of 
Rpb1(“wild-type” N792D, and “slow” C4/R749H), were a kind gift of D. Bentley. 
They were maintained in DMEM supplemented with 10% FBS, 1% penicillin/
streptomycin, 200μg/mL hygromycin, and 6.5μg/mL blasticidin. To stimulate the 
expression of Rpb1 mutants, cells were induced with 2.0 μg/mL doxycycline for 16 
hours and treated with 2.5 μg/mL α-amanitin for additional 42 hours.
METHOD DETAILS 
Manipulations in cells. To induce autophagy, MCF7 cells were incubated in EBSS 
(Gibco) medium for 3 hours. To inhibit mTORC1, Torin1 was added to the medium 
for 2 hours (250 nM; Tocris Bioscience, Bristol, UK). Cells were irradiated at 10Gy 
dose and then incubated for additional 18 hours at normal conditions. To arrest 
cells in mitosis, Taxol (Sigma-Aldrich, 1μM f.c. for 17 hours) was added to the 
growth medium. FuGENE6 (Roche) was used for transfection of DNA plasmids, 
DharmaFECT1 (Dharmacone) for transfection of siRNAs and in-vitro transcribed 
mRNAs, according to the manufacturers’ instructions. To impede the dynamics of 
transcribing RNA polII, cells were treated with Camptothecin (CPT, Sigma) to the 
final conc. of 6mM for the indicated times.
DNA cloning. Psi-Check2 vector with cloned FRT sequence and hygromycin-
resistance gene served as the basic vector for the construction of Pro-Lib. To clone 
human promoters upstream of the Renilla ORF in Pro-Lib, putative promoter 
regions were cloned between BglII and NheI sites of the basic Pro-Lib vector 
(Figure S1A) after addition of random barcodes and removal of the SV40 promoter. 
All barcodes were sequenced as well as the proximal parts of the cloned promoter 
regions to confirm their identity. All other cloning procedures were performed 
using standard procedures; DNA was extracted from gel using Agarose Gel DNA 
Extraction Kit (Roche); all constructs were sequenced. The list of the plasmids used 
in the study together with their details is available in Table S3.
Luciferase assay. Luciferase assay was measured using Dual-Luciferase Reporter 
assay kit (Promega). Cultured cells were lysed with passive lysis buffer for 15 min 
at room temperature. Renilla (Rluc) and Firefly (Fluc) enzymatic activities were 
assayed with the substrates supplied with the kit using Centro XS3 LB960 machine 
(Berthold technologies). Typically, expression of Fluc was used to normalize the Rluc 
expression. Myc activity was measured using Myc-reporter constructs (pGL3-M4 
and pGL3-M4-mut, (Nagel et al. 2008). MCF7 cells (1x105 cells) were plated in 12-
well plates and transfected with 200ng of the reporter constructs using Fugene-6 
(Promega). Luciferase activity was measured 36 hours after transfection.
Barcoded polysomal profiling. Sucrose gradients for separation of polysomes 
were usually prepared by gentle sequential addition of 2.2ml of the different 
sucrose solutions (e.i., 47, 37, 27, 17 and 7% in Tris-HCl pH=7.5 (f.c. 20mM), MgCl2 
(f.c. 10mM) and KCl (f.c. 100mM), supplemented with 2mM DTT, Ribosafe RNAse 
inhibitor (Bioline, 1μl/ml) and CHX (100μg/ml) into a 12-ml tube (Beckman, 9/16 
x 3 ½ in.) and left overnight at 4°C to achieve continuous gradient prior to the 
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centrifugation. Cells growing in subconfluent conditions (typically ≈80-85% 
confluency) were washed once with ice-cold PBS, collected into 15-ml tubes 
and incubated with PBS/cycloheximide (CHX, 100μg/ml) for 5 min on ice. After 
sedimentation (400xg for 3min), the cells were lysed in lysis buffer (20 mM Tris-
HCl (pH 7.5), 10 mM MgCl2, 100 mM KCl, 1% NP40) supplemented with EDTA-free 
cOmplete Protease Inhibitors (Roche), 2mM DTT, Ribosafe RNAse inhibitor (Bioline, 
1μl/ml) and CHX (100μg/ml) for 10min on ice. To remove cell aggregations, the 
lysates were passed three times through a 25G needle. The lysates were centrifuged 
1300xg for 10 min at 4°C and the supernatants were transferred into new tubes. 
From the cleared lysates, 500μl were loaded on top of each gradient, mounted 
on SW41TI rotor and centrifuged at 36000rpm for 2 hours at 4°C. Following the 
centrifugation, each gradient was split into 15 equal fractions of 760μl, which were 
subjected to RNA isolation using TRIsure (Bioline) according to the manufacturer’s 
instructions. RNA was precipitated from 750μl of the collected material, using 
2μl of GlycoBlue (Ambion) and 750μl of isopropanol, washed once with 70% of 
ethanol and reconstituted in 25μl of water. Typically, 7μl of total RNA were taken 
as a template for reverse transcription reactions using Tetro cDNA synthesis kit 
(Bioline) and oligo dT primers. Barcodes of the Pro-Lib transcripts detected by 
qRT-PCR using specific primers. To construct libraries ready for deep sequencing, 
barcodes were PCR amplificed using indexed primers bearing P5, P7 and Illuseq 
sequences, while each collected fraction was associated with a unique index. The 
PCR products were cleaned using QIAquick PCR purification kit (Qiagen), size 
selected on E-Gel SizeSelect 2% gels (Invitrogen) and sequenced using Illumina 
Hi-seq 2000 or 2500. 
RNA manipulations. RNA was isolated from cultured cells using TRI-sure reagent 
(Bioline) according to the manual, using Glycoblue (Ambion) as a carrier. RNA was 
typically reconstituted in 30μl of sterile nuclease-free water (Gibco) and stored at 
-20°C. To analyze RNA on agarose gels, a portion of isolated RNA was mixed with 
equal volume of 2xRNA-loading dye (Thermo Fisher Scientific), supplemented with 
20ng/ml Ethidium bromide, heated at 70°C for 5min and loaded on 1.5% agarose 
gel. After separation at 100mV for 30min, gels were visualized and documented. 
Reverse transcription was done using Tetro cDNA synthesis kit (Bioline) according 
to the manual. Typically, 7μl of total RNA was taken for a single RT reaction. Real 
time PCR experiments were performed using SensiFAST CYBR (Bioline) reagent 
and LightCycler 480II (Roche) using standard conditions.
In vitro synthesis of mRNA. To synthesize Renilla mRNA using nuclear extract, we 
used HeLaScribe Nuclear Extract in vitro Transcription System (Promega) according 
to the manufacturer’s protocol. Briefly, DNA templates including promoter, ORF, 
UTRs and polyA site were PCR-amplified from the appropriate pGEM-T vectors, 
isolated on agarose gels and cleaned. For a single reaction, 200ng of a clean 
template were transcribed with 7μl of nuclear extract, in a buffer containing 1.5mM 
MgCl2 in a siliconized RNAse-free 1.5-ml eppendorf tube (Ambion) at 30°C for 1.5 
hours. The reaction was stopped by addition of TRIsure compound (Bioline) and 
RNA was isolated, analysed on agarose gels, quantified using NanoDrop, compared 
using ImageJ and stored at -20°C. Transfection was done in 96-wells plates 
using Dharmafect1 agent (Thermo Scientific), according to the manufacturer’s 
instructions. Approximately 10ng of recovered mRNA were transfected as x1-
amount. Rluc activity was measured ≈24 hours following transfection. For m6A 
measurements, reconstituted synthetic RNA was furthermore cleaned using 
RNeasy kit (Qiagen). To synthesize Renilla mRNA using T7 RNA polymerase, we used 
HiScribe T7 High Yield RNA Synthesis kit (NEB) according to the manufacturer’s 
instruction. Briefly, PCR-produced DNA fragments encoding for Renilla ORF were 
transcribed in presence of Ribo m7G Cap Analog (Promega, 8mM f.c.) at 37°C for 2 
hours followed by DNAse treatment for 15 min and isolation of RNA. To produce 
transcripts with methylated content, N6-Methyladenosine-5’-Triphosphate 
(Trilink, 100mM stock conc.) was added together with ATP (supplied in the kit) at 
the indicated proportions. After recovery, the RNAs were polyadenylated using 
E.Coli Poly(A) polymerase (NEB) and purified. After recovery and analysis on gels, 
RNAs were transfected into living cells as described above or subjected to in-vitro 
translation.
In vitro translation of mRNAs. To translate mRNAs encoding for Rluc protein, 
rabbit reticulocytes system, nuclease treated (Promega) was employed, according 
to the manufacturer’s protocol. All reactions were done in volume of 25ml at 30°C 
for 10 min. To quantify the produced Rluc protein, aliquots of 5ml were taken for 
luciferase measurements using Dual-Luciferase Reporter assay kit (Promega). 
Northern blotting. Total RNA was extracted from growing MCF7 cells as 
described and enriched for mRNA using Oligotex kit (Qiagen). Equal volumes of 
reconstituted RNA were separated on 1.2% agarose gel supplemented with 0.66% 
(vol/vol) formaldehyde and transferred onto Amersham Hybond-N+ membrane 
(GE Healthcare). RNA probes targeting Renilla or Firefly  mRNAs were produced 
by in-vitro transcription (T7 high yield kit, NEB) of PCR fragments encoding for 
sequences complementary to these transcripts (see Table S4 for used oligos) 
using 32P(α)-UTP. Following cleaning of the probes using MicroSpin G-50 columns 
(GE Healthcare), hybridization was performed in ULTRAhyb Hybridization buffer 
(Ambion) rotating at 68°C for 4 hours. The membrane was washed twice with 2xSSC 
buffer supplemented with 0.1%SDS and twice with 0.2xSSC buffer supplemented 
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with 0.1%SDS. The signal was detected by FujiFilm FLA-3000 PhosphorImager and 
analyzed using ImageJ.
Measurement of m6A content. To quantify the m6A content of RNA, EpiQuik 
m6A RNA Methylation Quantification Kit (Epigentek) was used. Briefly, equal 
volumes of RNA solution (4-8μl) were processed according to the manufacturer’s 
instructions, aside with the negative, positive and standards controls. 
5’RACE analysis. Generally, 5’RACE experiments followed the procedure 
established for 5’ RACE System for Rapid Amplification of cDNA Ends, v2.0 
(Invitrogen). Briefly, total RNA was extracted with TRIsure (Bioline) and 
subsequently poly-A selected with Oligotex Direct mRNA mini kit (Qiagen).  For 
each 5’ RACE assay, 500ng of poly-A selected mRNA were used for cDNA synthesis 
with the following primer: CCCTTCTCCTTGAATG. Synthesized cDNA were purified 
with QIAquick PCR purification kit (Qiagen). Then the cDNA were dC-tailed with 
TdT for 10min at 37oC and a first round PCR was performed with a gene specific 
primer (GSP2), AGTTTCCGCATGATCTTGCTTG, and Abridged Anchor Primer 
(AAP). A nested PCR was performed with a nested gene specific primer (GSP1), 
GTTGATGAAGGAGTCCAGCACGTT, and Abridged Universal Amplification primer 
(AUAP). For determination of the sequences of 5’ RACE PCR products, the nested 
PCR products were ligated into pGEM-T vector (Promega) and transfected into 
competent bacteria. At least 20 different bacterial colonies from each ligation 
were subsequently analyzed with Sanger sequencing.
3’RACE analysis.
The protocol was adapted from 3’RACE system for rapid amplification 
of cDNA ends (Invitrogen). Briefly, total RNA was poly-A selected and 
reverse transcribed with oligo(dT)-containing adapter primer (AP) 
GGCCACGCGTCGACTAGTACTTTTTTTTTTTTTTTTT. Synthesized cDNA was 
treated with Rnase H to remove residual RNA templates and PCR-amplified with 
Rluc specific primer CTGAGAGTGTCGTGGACGTGA and AAP. A nested PCR was 
performed with a nested Rluc primer GCCTAAGATGTTCATCGAGTCC and AAP. 
Sequencing library preparation of 5’ and 3’RACE
PCR products from 5’ and 3’ RACE preparations were PCR-amplified with Illumina 
sequencing compatible primers (p5 primer, 5’RACE-p7 primer, and 3’RACE-p7 
primer). PCR products were then purified with CleanPCR magnetic beads 
(CleanNA), and pooled with equal molar, ran on Illumina Miseq platform.
Poly(A) tail analysis.
Determination of poly(A) tail-length was performed with USB® Poly(A) tail-
length assay kit (Affymetrix) following the manufactor’s protocol. In short, in-
vitro transcribed RNA was G/I tailed, and reverse-transcribed with specific adapter 
primer (sequence not provided). The poly G/I tailed cDNA was then amplified with 
a Rluc specific primer (GCGTGCTGAAGAACGAGCAGTAA) and a provided universal 
PCR reverse primer. Finally, PCR products were resolved on a 2.5% agarose gel 
with ethidium bromide. 
Lentiviral infection. To generate viruses with the Renilla-expressing plasmid, 
HEK293T cells were plated 24h prior transfection. For virus production, 3.5μg 
of pVSV-G, 5μg of pMDL-RRE and 2.5μg of pRSV-REV was transfected with 10μg 
of the expression plasmid pLenti-puro-Rluc. Lentivirus-containing supernatant 
was harvested 48h after the transfection, filtered through a 0.45μm membrane 
(Milipore Steriflip HV/PVDF) and kept at -80°C. Subsequently, to infect MCF7 cells, 
1x106 cells were plated in 10-cm dish one day prior infection. For low MOI infection, 
cells were infected with 20μL of the virus-containing supernatant; for high MOI 
infection, cells were infected with 900μL (45-fold) of the supernatant. Cells were 
refreshed with DMEM 18h after infection and subsequently recovered for 24h. 
Afterwards, low MOI-infected MCF7 cells were selected with 1 mg/mL puromycin 
and high MOI-infected MCF7 cells were selected with various concentrations of 
puromycin (1ug/mL, 5ug/mL, 10ug/mL and 25ug/mL) for 1 week. 
CRISPR/Cas9-mediated mutagenesis. For the mutagenesis of c-Myc TATA box 
sequence, lentivirus containing sgRNAs targeting the TATA box sequence were 
generated and subsequently used for infecting MCF7 cells as described above. 
After puromycin (2μg/ml) selection, cells were plated in a 96-well plate following 
serial dilutions in order to achieve single cell clones of the Cas9-generated mutants. 
Several single cell clones were collected, expanded and sequenced. To sequence 
the indel mutations within the c-Myc locus, genomic DNA was extracted from the 
grown colonies using DNeasy Blood and Tissue Kit (Qiagen), PCR amplified using 
c-Myc promoter-specific primers, sub-cloned into pGEM-T vector (Promega) and 
sequenced. 
 
Western blotting. MCF7 cells were washed with ice-cold PBS and scraped off 
the plate. Cells were centrifuged at 1000xg for 10min at 4oC. Subsequently, cell 
pellets were lysed, by adding an appropriate amount of ice-cold lysis buffer (20mM 
Tris-HCl at pH 7.5, 150mM NaCl, 1.8mM MgCl2 and 0.5% NP40) supplemented with 
cOmplete protease inhibitor cocktail (Roche) and 1mM DTT. Cell lysates were 
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incubated on ice for 20min with occasional vortexing followed by centrifugation 
at 15000xg for 15min at 4oC. Protein concentrations were determined using Pierce 
BCA protein assay kit (Thermo Scientific). Proteins were separated on SDS-PAGE 
gels and transferred onto Nitrocellulose membrane (Bio-rad, 0.2μM), which was 
blocked in 5% Blotting-grade blocker and probed with the indicated antibodies. 
All antibodies were diluted in PBS-0.25% Tween solution. For detection, blots 
were reacted with the SuperSigna West Dura Extended Duration Substrate 
(ThermoFisher). Images were captured with Chemidoc XRS+ (Biorad) and analyzed 
with Image Lab software; quantifications were done using ImageJ.
m6A RNA immuno-precipitation (MeRIP). Immunoprecipitation of m6A was 
adapted from the protocol of EpiMark® N6-Methyladenosine Enrichment Kit (New 
England Biolabs). Total RNA was isolated as mentioned above and enriched for 
mRNA using Oligotex mRNA kit (Qiagen) following manufacturer’s instruction. 
The isolated mRNA was fragmented with RNA fragmentation reagent (Ambion) 
for 5min, 94oC and purified through ethanol precipitation.  To bind antibody to 
the beads, protein G beads (Invitrogen) were pre-incubated with 1μL of anti-
m6Aantibody (Neb, Cat. E1610S) in IPP buffer (150 mM NaCl, 10 mM Tris-HCl, pH 7.5, 
0.1% NP-40)at 4oC. Subsequently, the beads were washed twice in IPP buffer and 
incubated with RNA for 3h with head-to-tail rotation at 4oC (10% of the material 
were kept as input control). Afterward, beads were washed twice in IPP buffer, 
twice in low salt buffer (50 mM NaCl, 10 mM Tris-HCl, pH 7.5, 0.1% NP-40), and 
twice in high salt buffer (500 mM NaCl, 10 mM Tris-HCl, pH 7.5, 0.1% NP-40). RNA 
was eluted with 30μL buffer RLT (Qiagen, Cat. 79216) for 5min and subsquently 
purified through ethanol precipitation. For quantification of precipitation, both 
input samples and IP eluates were examined by qRT-PCR as described above. 
RNAPII immuno-precipitation. MCF7 cells growing on 15-cm dishes were treated 
with CPT (Sigma, 6mM f.c.) or DMSO (as a control) for 5 hours. After collection on 
ice, the cells were incubated in 8ml of PBS supplemented with 1% formaldehyde 
for 10 min at room temperature in constant rotation. After quenching with glycine 
(0.125M f.c.) for 5 min, the cells were spun, washed once with PBS, flash-frozen 
in liquid nitrogen and kept at -80°C. After thawing in 1ml of lysis buffer (50 mM 
HEPES-NaOH-pH7.5, 150 mM NaCl, 5 mM MgCl2, 0.1% NP40) supplemented with 
EDTA-free cOmplete Protease Inhibitors and PhosSTOP (Roche), the lysate was 
divided into three equal 2-ml eppendorf tubes and sonicated at 4°C using Bioraptor 
(Diagenode) for 10 cycles (each cycle including 30sec of high-power sonication 
followed by 30sec pause). The lysates were centrifuged for 10 min. at 1800xg at 
4°C to remove unbroken cells. Equal volumes of supernatants were added to 20 µl 
of Dynabeads-Protein G suspension (Life Technologies) pre-coupled with 5μg of 
anti-RNA polymerase II antibodies (Millipore, clone CTD4H8) or normal mouse IgG 
(Santa Cruz) in PBS and 1% BSA for 2 hours at room temperature. The IP reaction 
was carried out for 2 hours at 4°C with constant rotating. After that, the beads 
were washed once with the regular lysis buffer and three times with stringent lysis 
buffer (as detailed above, but with 300 mM NaCl). The last washing was done with 
PBS, and the beads were transferred into new 1.5-ml tubes and the bound proteins 
were eluted and reverse-crosslinked by incubation with 50μl of 1x Laemmli sample 
buffer at 100°C for 10min. After collection, the eluates were resolved on 8% SDS-
PAGE and probed with the indicated antibodies.
Ribosomal profiling. Ribosome Profiling (RP) was performed as previously 
described (Loayza-Puch et al. 2016). Briefly, CHX (100μg/ml) was added to the 
medium of growing cells and incubated for 5min at 37°C. Approximately 30x106 
cells were collected in ice-cold PBS and lysed in lysis buffer (20 mM Tris-HCl 
pH 7.8, 10 mM MgCl2, 100 mM KCl, 1% Triton X-100, 2 mM DTT, 100μg/ml CHX, 
cOmplete protease inhibitors (Roche). Lysates were passed through a 26G needle 
(BD bioscience) for further homogenization, and centrifuged at 4°C 1300xg for 
10 minutes. Supernatants were treated with 2.5U/µl of RNase I (Ambion) for 
45 min at room temperature in gentle constant rotation. Lysates were loaded 
onto a linear sucrose gradient (7%-47%, as detailed above), and fractionated by 
ultracentrifugation, using a SW-41Ti rotor at 36000 rpm (221632.5g) during 2 
hours. The sucrose gradient was divided into 14 fractions of 830μl. The monosome-
enriched sucrose fractions (7 to 10) were collected and treated with proteinase K 
(PCR grade, Roche), in presence of 1% SDS. The so-released ribosome protected 
fragments (RPFs) were purified using TRIsure reagent (Bioline), following the 
manufacturer’s instructions. RPFs between 30 and 33 nucleotides in length were 
size-selected in 10% acrylamide gel and isolated. The 3’ ends of the RPFs were 
dephosphorylated by treatment with T4 polynucleotide kinase (New England 
Biolabs) for 6 hours at 370C in MES-NaOH buffer (100mM MES-NaOH, pH 5.5, 
10mM MgCl2, 10mM β-mercaptoethanol, 300mM NaCl). 3’ adaptor (RA3) was 
ligated using T4 RNA ligase 1 (New England Biolabs) for 3.5 h at 370C, in absence 
of ATP. Ligation products were size selected in 10% acrylamide gel, and the 5’ 
ends were phosphorylated by treatment with T4 polynucleotide kinase for 30 
minutes at 370C, in presence of 1mM ATP. 5’ adaptor (RA5) was ligated using T4 
RNA ligase 1 (New England Biolabs) during 2.5h at 370C, and the ligation products 
were selected in 10% acrylamide gel. Ribosomal RNA depletion was performed 
by biotin-streptavidin affinity purification using biotinylated ribosomal RNA 
probes and streptavidin dynabeads. Retro-transcription of the ligation products 
into cDNA was performed using Super Script III reverse-transcriptase (Invitrogen) 
following the manufacturer’s instructions, and the primer RTP. PCR amplification 
Chapter 2
Transcription impacts the efficacy of mRNA translation via co-transcriptional 
N6-adenosine methylation
2
5958
was performed using the forward primer RP1, and the reverse primer RPI that 
contained a hexanucleotide index used to multiplex different samples during 
next generation sequencing (NGS). PCR products were size selected by E-Gel 
electrophoresis (Invitrogen), and submitted to NGS using HiSeq 2500 System 
(Illumina). The sequence of 3’ and 5’ adapters, RTP, RP1 and different RPI primers 
is available in Table S5.
RNA-seq 
Total RNA Isolation. Total RNA was extracted using TRIzol reagent (15596-018, 
Ambion life technologies) according to the manufactures protocol. Briefly, 0.2x 
volumes of chloroform (Chloroform stab./Amylene, Biosolve) was added to the 
Trizol homogenate and the tube(s) (Falcon, 15mL) were shaken vigorously. The 
tube(s) were incubated for 2-3 minutes at room temperature and centrifuged 
(Hettich, rotanta 46 RS) for 1 hour at 4 °C. Approximately 70% of the upper aqueous 
phase was transferred to a clean 15 mL tube and 0.5x volume of isopropanol 
(33539, Sigma-Aldrich,) was added. The tube(s) were incubated overnight at -20 
°C and centrifuged for 30 minutes at 4 ° C. The supernatant was removed and 
the pellet was washed twice with 80% ethanol  (32221-2.5L, Sigma-Aldrich). 
The total RNA pellet was air-dried for 8 minutes and dissolved in an appropriate 
volume of nuclease free water (Ambion) and quantified using Nanodrop UV-
VIS Spectrophotometer.  The total RNA was further purified using the MinElute 
Cleanup Kit (74204, Qiagen) according to the manufactures instructions. Quality 
and quantity of the total RNA was assessed by the 2100 Bioanalyzer using a Nano 
chip (Agilent, Santa Clara, CA).  Total RNA samples having RIN>8 were subjected to 
library generation.
TruSeq Stranded mRNA sample preparation. Strand-specific libraries were 
generated using the TruSeq Stranded mRNA sample preparation kit (Illumina Inc., 
San Diego, RS-122-2101/2) according to the manufacturer’s instructions (Illumina, 
Part # 15031047 Rev. E). Briefly, polyadenylated RNA from 1000ng intact total RNA 
was purified using oligo-dT beads. Following purification the RNA was fragmented, 
random primed and reverse transcribed using SuperScript II Reverse Transcriptase 
(Invitrogen) with the addition of Actinomycin D. Second strand synthesis was 
performed using Polymerase I and RNaseH with replacement of dTTP for dUTP. 
The generated cDNA fragments were 3’ end adenylated and ligated to Illumina 
Paired-end sequencing adapters and subsequently amplified by 12 cycles of PCR. 
The libraries were analyzed on a 2100 Bioanalyzer using a 7500 chip (Agilent, Santa 
Clara, CA), diluted and pooled equimolar into a 10nM multiplex sequencing pool.
Sequencing. The libraries were sequenced with 65 base single reads on a 
HiSeq2500 using V4 chemistry (Illumina Inc., San Diego).
Quantification and statistical analysis
While mentioned, n represents the number of biological repeats of the same 
experiment. Data are represented as mean±SEM. P-values presented in Figures 
3A,E; 4A,D; S5B,C; S6A,B were calculated using Wilcoxon’s test. P-values mentioned 
in other figures were calculated using t-test (one-tail distribution, homoscedastic 
variance). In all figures, *=p<0.05, **=p<0.01, ***=p<0.005, ****=p<0.001.  
Polysomal data analysis and preparation of heatmaps. Polysomal fractions 
and promoter vectors were identified by their unique indexes and barcodes, 
respectively. Expression count matrix was derived by counting the frequency of each 
barcode in each fraction. To avoid fluctuations due to low coverage, only vectors 
covered by at least 10,000 counts (summation over all fractions) were included 
in the analyses. For heatmap display, vector counts (rows) were standardized 
to mean=0 and SD=1. Heatmaps were generated using the EXPANDER package 
(Ulitsky et al. 2010). Order of promoter vectors in the heatmap was determined by 
hierarchical clustering of the rows.    
RNA-seq and Ribo-seq analysis. Sequenced reads were aligned to a reference set 
of human curated protein-coding transcripts (plus the five human rRNA transcripts) 
using Bowtie (Langmead et al. 2009). This reference set of transcripts was based 
on Ensembl’s gene annotations (release 69). For genes with multiple isoforms, 
the one with longest coding DNA sequence (CDS) region and, in case not unique, 
the one with longest UTRs among the ones with the longest CDS, was selected 
to represent the gene. Only uniquely mapped reads were used in subsequent 
analyses. RNA expression levels and ribosome occupancy were estimated by 
calculating reads per kilobase of mRNA per million reads (RPKM) per transcript, 
taking into account either all reads that map to the transcript (for estimation of 
RNA levels using RNA-Seq data) or only those mapping to its CDS (for estimation 
of ribosome occupancy). In estimation of ribosome occupancy in CDS, 5’ ends of 
reads were offset 12 nucleotides to the 3’ direction to match the P-site location 
of ribosome (Ingolia et al. 2009). Translation efficiency (TE) was estimated by the 
(log2) ratio between ribosome occupancy and mRNA level. Only genes with at least 
20 reads in RNA-seq and Ribo-seq samples were included in analyses. 
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GRO-seq analysis. Sequenced reads were aligned to the human genome (hg19) 
using bowtie2, and number of reads mapping to annotated genes (Ensembl v69) 
were counted by HTseq (Anders et al. 2015). Quantile normalization was then 
applied to allow comparisons between diff erent samples. Only genes covered by 
at least 20 reads were included in the analysis.
Data and software availability 
The deep sequencing datasets generated in this study have been deposited in the 
GEO DB under accession number GSE96643.
Supplemental data
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Supplemental Figure 1
Figure S1.
Setup of the promoter library (Pro-Lib) and barcoded polysomal profi ling (BPP), Related to Figure 1. (A) 
Schematics of the Pro-Lib vector. The reporter Rluc gene is fl anked upstream by sequences encoding 
for putative promoters of interest (magenta colored) and downstream by unique 10-nt barcodes (also 
magenta colored). Transcription of the control Fluc gene is driven by HSV-TK promoter in all vectors. (B) 
Several Pro-Lib vectors with the indicated regions cloned upstream of Rluc gene were integrated into 
MCF7/FRT cells, grown separately and subjected to dual Rluc/Fluc assay. Note the uniform expression 
of the tested constructs that is substantially higher than the background signal (assessed by expression 
of vectors with no promoter or with random intron sequence cloned instead of a promoter) and milder 
than the expression of the strong SV40 promoter. Data are represented as mean±SEM of n=3. (C) Total 
RNA isolated from fractions of a typical BPP experiment were separated on 1.5% agarose gels and 
documented. Note the characteristic segregation of RNA as well as the relative enrichment of ribosomal 
RNAs in the polysomal fractions. (D) Total RNA concentrations in the diff erent fractions were measured 
following lysis of cells in the presence or absence of EDTA and polysomal profi ling procedure. Note 
the dramatic drop of the RNA content in the fractions 9-13 upon presence of EDTA in the lysis buff er. 
(E) BPP experiment identifi es two Rluc transcripts (driven by SV40 and CD44 promoters) exhibiting 
super-sensitivity to the inhibition of mTORC1. Note the multiple barcodes for each promoter showing 
identical behavior. (F) The transcripts mentioned in (E) contain putative 5’TOP sequences (marked in 
blue). The TSS of the SV40 promoter was reported previously (Byrne et al., 1983), while the TSS of the 
CD44-driven construct was determined by 5’-RACE analysis in this study. 
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Figure S2. 
Effect of TATA box on TE, Related to Figure 2. (A) Pro-Lib vectors encoding for promoters with TA-
rich regions at their 3’ ends result in Rluc mRNAs shifted to the denser fractions of the gradient, 
compared to other transcripts (e.g., under SPTBN1 promoter). (B) Average standardized profiles of 
polysome fractions for the TATA+/TATA- paired constructs in Pro-Lib. (C) Promoter region of ASNSD1 
gene yields better translated Rluc mRNAs when supplemented with an artificial TATA box at its 3’end. 
Cells expressing Rluc mRNAs from either native ASNSD1 promoter or with artificial TATA box were 
subjected to BPP and plotted for a direct comparison of TE (left panel). To test the robustness of the 
positive effect of TATA on TE, cells were subjected to various stress conditions, prior to BPP (right 
panels). Note that in all listed conditions the presence of TATA box enhances TE. (D) Point mutagenesis 
of the artificial TATA box reduces mRNA levels and prevents super-induction of the protein production. 
SZT2 and ASNSD1 promoters supplemented with an artificial TATA box were subjected to site-directed 
mutagenesis of the TATA box sequence (muTATA). Levels of the Rluc mRNAs and protein compared 
to the native promoters (lacking TATA) are shown; data are represented as mean±SEM of n=3. (E) 
Rluc mRNAs resulting from either native ASNSD1 promoter, one with the artificial TATA box (+TATA) 
or with a point-mutated TATA sequence (muTATA) were subjected to the BPP procedure. Note the 
shift towards denser fractions caused by the artificial addition of TATA box as well as the shift to the 
opposite direction upon mutation of the TATA sequence. (F) Screenshot of the DBTSS database (release 
9.0) showing the distribution of TSS of c-Myc gene in MCF7 cells. Note that most of TSSs stem from 
a single TATA box-containing promoter (see zoom-in window). (G) Genotyping of the c-Myc proximal 
promoter region of the second clone bearing modified c-Myc TATA box. Numbers on the left represent 
relative abundances of the different alleles. (H) Lysates of the clone described in (G) were subjected 
to polysomal profiling and plotted against wild-type MCF7 cells. SEM represents three measurements 
of a characteristic gradient; n=2. ***p<0.005, ****p<0.001. (I) Lysates of the two clones bearing 
modified c-Myc TATA boxes together with wild-type MCF7 cells (WT TATA) and cells transfected with 
vector encoding for c-Myc (Myc OE), were resolved on SDS-PAGE and probed for c-Myc and GAPDH 
proteins. Replicates on the blot represent biological repeats. (J) Relative quantification of the c-Myc 
bands presented in (I). (K) TE of a control gene (ALG8) was assessed by probing polysomal fractions 
described in Figure 2J with primers detecting ALG8 mRNA. SEM represents three measurements of a 
characteristic gradient; n=3. 
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Supplemental Figure 3
Figure S3. 
Analysis of Rluc mRNAs, Relates to Figures 2,3,5 and 6. Rluc mRNAs transcribed by ASNSD1 (A) or SZT2 
(B) promoters either lacking or bearing an artifi cial TATA box were subjected to 5’RACE analysis in order 
to determine their TSSs. Reads were plotted in a quantitative manner using IGV software. Note the 
fi rst ATG of the Rluc ORF and the precise focusing of the TSS by the TATA box. (C) Evaluation of the 
eff ect of the diff erent 5’UTRs on TE. Rluc transcripts bearing the diff erent 5’UTRs identifi ed in A,B 
(see the numbered arrows) were transcribed in vitro using T7 RNA polymerase, polyadenylated and 
transfected into MCF7 cells in fold-wise amounts. Renilla luciferase activity was measured 24 hours 
later and plotted in a relative manner to draw the trend lines that represent the respective ratios of 
translation. The rightmost panel shows the absolute Rluc signals; n=4. (D) Rluc mRNAs expressed from 
either induced or non-induced TRex-Rluc gene were subjected to 5’RACE analysis. Reads (numbers of 
sequenced colonies) were plotted in a quantitative manner on a scale ranging from TATA box (-243) to 
ATG (+1). (E) Rluc transcripts produced in vitro using HeLa extract in optimal conditions (1.5mM Mg++), 
upon high MgCl2 (3mM Mg++) or from promoter with mutated TATA element (muTATA) were subjected 
to 5’- and 3’-RACE analyses. The reads from both assays were analyzed and plotted in a quantitative 
manner using IGV software. (F) Transcripts described in (E) were subjected to analysis of the length of 
polyA-tails. (G) The TRex-Rluc cassette was induced for 24 hours in cells transfected with the indicated 
siRNAs. After isolation of total RNA, the 5’- and 3’-ends of the Rluc mRNAs were determined as detailed 
in (E). 
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Figure S4. 
Global TE assessment of the Pro-Lib mRNAs, Relates to Figure 3. Barcoded Rluc mRNAs with suffi  cient 
read coverages (>10.000 reads over 15 polysomal fractions) in three independent BPP experiments 
were divided into two main groups by hierarchical clustering. One arm includes barcodes that showed 
peak in fractions 9-11 (lower TE, A-B) and the other arm includes barcodes whose polysomal profi le 
peaked in fraction 11-13 (higher TE, C-D). Plots to the right of the heatmaps show the mean profi le of 
the vectors assigned to each group over the three repeats; error bars=SD. 
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Figure S5. 
Transcription rates impacts translation, Relates to Figures 3 and 4. (A) Segregation of the induced versus 
non-induced Rluc mRNAs on sucrose gradients. Cells expressing barcoded Rluc gene were treated 
for 21 hours to induce the expression of Rluc or left untreated, and subjected to BPP procedure. (B) 
Upper panels: test for correlation between mRNA expression and TE, as described in Figure 3E, was 
performed here on data from BJ cells in quiescent, senescent, and transformed states. Lower panels: 
direct comparison between 10% of mRNAs with the lowest and 10% with the highest abundance. (C) In 
MCF7 cells, a similar correlation was tested in p53-activated (by Nutlin3 treatment) versus the control 
cells. Both datasets are from (Loayza-Puch et al., 2013), representation as detailed for (B). (D) Cells with 
induced Rluc were treated with CPT (or DMSO) for 5 hours and subjected to BPP analysis. 
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Figure S6. 
Relates to Figures 4,5 and 6. (A) Genes with high ribosomal occupancy in their 5’UTRs show overall 
reduced TE in both BJ and MCF7 cells; p-values were calculated Wilcoxon’s test. (B) These genes do 
not display any clear correlation between their transcription rate and TE (showing two independent 
replicates), and were removed from the genome-wide analysis. (C) Treatment with CPT causes 
attenuation of translation. Transcripts showed in Figure 4E and additional mRNAs were detected 
in polysomal profi ling experiments using primers against their 3’UTRs. (D) Rluc mRNAs produced in 
cells stably expressing Lenti-Rluc cassette integrated at either single- or multiple-copy numbers, were 
subjected to MeRIP procedure and analyzed by qRT-PCR. In each experiment, the level of recovery 
from cells with multi-copy integration was calculated relatively to the recovery of the single-copy 
population; n=4. (E) Rluc mRNAs transcribed from the promoter pairs with or without intact TATA box 
element were subjected to MeRIP procedure and analyzed by qRT-PCR; n=2. (F) Effi  ciency of METLL14 
and YTHDF1 siRNA-mediated knock-down. MCF7 cells were transfected with siRNAs targeting 
METTL14 or YTHDF1 genes or control non-targeting siRNA. After 56 hours, the cells were harvested, 
subjected to RNA isolation and tested for the levels of the respective mRNAs using qRT-PCR. (G) MCF7 
cells transfected with the indicated siRNAs were subjected to polysomal profi ling procedure and an 
average levels of RNA in the collected fractions were measured using NanoDrop and plotted; n=2. (H) 
Cells expressing “normal speed” or “slow” mutants of RNAPII were subjected to polysomal profi ling 
on sucrose gradients. Several mRNAs were detected using qRT-PCR to monitor changes in their TE; a 
characteristic profi le is shown, n=2. 
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Metabolism of messenger RNAs (mRNAs) consists of multiple steps, from 
transcription, through splicing, export to the cytoplasm, localization, translation to 
proteins and, fi nally, degradation. These steps, which are crucial to ensure correct 
genetic expression, have long been considered as separate events occurring at 
distinct time points and diff erent locales. Recent studies suggest that they are not 
only interconnected, but might also be coupled to the initial process - transcription. 
Initial studies in the fi eld showed that the occurrence of exon inclusion and intron 
retention could be altered in HEK293 cells with “slow” and “fast” RNA Polymerase 
II (RNAPII) mutants, suggesting that the rate of transcriptional elongation is crucial 
for the appropriate splice form (Fong et al., 2014). Another important step of mRNA 
life is its export from the nucleus into the cytoplasm. It has been suggested that 
the export process is not merely a sequential event, but the regulation happens co-
transcriptionally as well. In yeast, a group of factors that function in transcription 
elongation and mRNA export form a “Transcription/Export” (TREX) complex, which 
couples to RNA Pol II throughout the entire RNA molecule (Sträßer et al., 2002). 
As splicing and export could occur co-transcriptionally, they might be directly 
aff ected by the dynamics of transcription. However, how post-transcriptional 
processes – such as degradation and translation - could be coupled to transcription? 
When single-molecule mRNA decay study measured stabilities of two mitotic 
mRNAs, SWI5 and CLB2 in yeast, they found that the precise control of their 
cytoplasmic decay is largely regulated by their promoters via co-transcriptional 
binding of a co-factor, Dbf2p (Trcek et al., 2011). Similarly, Bregman et al. showed 
that promoter sequences can recruit Rap1p protein and enhance the decay of its 
transcribed mRNA in yeast (Bregman et al., 2011). Thus promoters, elements that 
drive the transcription, are capable of regulating the destiny of mRNAs after its 
export into the cytoplasm. Recent evidences from several studies suggest that also 
the mRNA translation could be regulated, to a large extent, by transcription. First, 
yeast promoters were shown to recruit RNAPII subunits to facilitate translation of 
specifi c transcripts (Harel-Sharvit et al., 2010). Similarly, upon glucose starvation, 
specifi c yeast promoters were shown to bind Hsf1 to direct mRNA localization 
and the effi  ciency of translation in the cytoplasm (Zid and O’Shea, 2014). These 
two studies demonstrate the ability of yeast promoters, via co-transcriptional 
recruitment of eff ector proteins, to regulate translation of specifi c mRNAs. 
Recently, we discovered a direct genome-wide link between transcription and 
translation in mammalian cells (Slobodin et al., 2017). While testing the eff ect of human 
promoters on translation, we identifi ed a positive correlation between the levels of 
mRNA expression on their capabilities to bind ribosomes (i.e., translational effi  ciency, 
or TE). However, we observed that mRNA levels present in the cytoplasm are not the 
factor that dictates TE directly. Instead, we found that rates of transcription (i.e. the 
strength of the promoter activity to recruit RNAPII and the speed of transcriptional 
elongation) positively regulate TE across diff erent mammalian cell lines. 
To study how this link is maintained, we examined a possible role of a specifi c 
RNA modifi cation, N6-methyladenosine (m6A), in coordinating the two processes 
(Slobodin et al., 2017). Indeed, upon knock-down of several m6A-regulatory 
factors, both “writers” and “readers”, we observed a striking positive eff ect 
on the TE of mRNA that was characterized by slow transcription rates. Direct 
immunoprecipitation of m6A-modifi ed mRNAs demonstrated signifi cant 
diff erence between the methylation levels of the repressed and induced 
transcripts, suggesting that mRNAs that are “repressed” (i.e., possess low levels 
of transcription), have higher m6A content. This, in turn, represses TE, therefore 
linking ineffi  cient transcription to ineffi  cient translation. Finally, by artifi cial slow-
down of RNAPII dynamics, we showed that the process of m6A modifi cation on 
mRNA is likely to be co-transcriptional.
Our study provides an additional evidence that transcription machinery is 
intrinsically linked with the process of translation and support the theory that the 
fate of a mRNA molecule could be in part pre-determined during transcription. 
Future studies should address the hidden link between RNAPII and m6A 
methylation complex and reveal how the speed of RNAPII is translated into the 
m6A content deposited on the transcript. Additionally, the exact role of m6A in 
translation still remains ambiguous. While we proposed an inhibitory role of m6A 
in translation, several recent studies found it stimulatory (e.g., Wang et al., 2015). 
The paradox could be partially explained by the precise location of the modifi ed 
residue within the transcript (e.g., coding regions versus untranslated regions). 
Future research should examine this hypothesis and uncover how cells determine 
the precise sites of m6A deposition. 
Fast RNA Pol II
Slow RNA Pol II
More methylation footprint on the way
Less methylation footprint on the way
RNA
RNA
Translation
Translation
Amount of RNA produced
Figure 1.
Diff erent transcription elongation rates dispose distinct m6A footprint on mRNAs, resulting in 
contrasting translational outcomes.
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mRNAs are modified by a myriad of epigenetic alterations of which little 
functional knowledge is present.  The functional investigation of the role of these 
RNA modifications is just emerging, and is expected to increase in volume in the 
coming few years. With the increasing knowledge of m6A regulation, its role in 
gene expression, involvement in diseases and the potential to serve for diagnosis 
(e.g. in cancer) is expected to become much clearer in the near future. The possible 
applications of RNA modifications, including drug development targeting m6A 
machineries and thus altering the epigenetic environment, could open up new 
avenues to a better and more effective diagnosis and treatment of human diseases 
stemming from imbalanced gene expression.
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Abstract
Background
Functional characterization of noncoding elements in the human genome is a 
major genomic challenge, and the maturation of genome-editing technologies 
is revolutionizing our ability to achieve this task. Oncogene-induced senescence 
(OIS), a cellular state of irreversible proliferation arrest that is enforced following 
excessive oncogenic activity, is a major barrier against cancer transformation, and 
therefore bypassing OIS is a critical step in tumorigenesis. Here, we aimed at further 
identification of enhancer elements that are required for the establishment of OIS.
Results
We first applied genome-wide profiling of enhancer-RNAs (eRNAs) to systematically 
identify enhancers that are activated upon oncogenic stress. DNA motif analysis 
of these enhancers indicated AP-1 as a major regulator of the transcriptional 
program induced by OIS. We thus constructed a CRISPR-Cas9 sgRNA library 
designed to target OIS-induced enhancers that are putatively regulated by AP-1, 
and used it in a functional screen. We identified a critical enhancer that we dub 
EnhAP1-OIS1 and validated that mutating the AP-1 binding site within this element 
results in OIS bypass. Furthermore, we identified FOXF1 as the gene regulated by 
this enhancer, and demonstrated that this target gene mediates EnhAP1-OIS1 effect 
on the senescence phenotype.
Conclusion
Our study elucidates a novel cascade mediated by AP-1 and FOXF1 that regulates 
OIS and further demonstrates the power of CRISPR-based functional genomic 
screens in deciphering the function of noncoding regulatory elements in the 
genome.
Keywords
CRISPR – Functional screen – Enhancers – Oncogene-induced senescence - Gene 
regulation – AP1- FOS – JUN – FOXF1
Background
Over the last decade, large-scale genomic projects identified hundreds of 
thousands of regulatory elements in the human genome, most of them are putative 
enhancers(Djebali et al., 2012; ENCODE Project Consortium, 2012). Identification 
of candidate enhancer regions was mainly based on profiling of characteristic 
histone modifications (e.g., H3K27ac and H3K4me1) and binding of transcriptional 
activators (e.g., p300). Recently, eRNA expression, typically transcribed bi-
directionally at promoter-distal cis-regulatory elements, was indicated as a 
sharp feature of active enhancers, and was utilized for systematic discovery of 
enhancers across the genome(Andersson et al., 2014). Importantly, changes in 
eRNA production correlate with changes in the enhancer activity(Banerji et al., 
1981; Heintzman et al., 2007). Yet, functional characterization of the plethora 
of candidate enhancer elements is a major genomic challenge(Rada-Iglesias et 
al., 2011). High-throughput reporter assays to probe the functions of regulatory 
regions were developed in recent years(Kim et al., 2010). However, these methods 
separate putative regulatory elements from their native chromosome, so that 
any effect of chromatin context and long range regulatory interactions is lost. 
Furthermore, definitive demonstration of the function of regulatory element 
requires their perturbation in situ. The maturation of novel genome-editing 
technologies is revolutionizing our ability to interrogate the function of the 
noncoding genome. This potential was demonstrated by pioneering CRISPR-based 
functional genomic screens that systematically targeted noncoding elements in 
the human genome(Amano et al., 2009; Bulger and Groudine, 2011; Levine, 2010; 
de Santa et al., 2010).
In one of these CRISPR-based functional genomic screens we focused on oncogene-
induced senescence (OIS), which is a cellular state of irreversible proliferation 
arrest that is enforced in face of excessive oncogenic activity (oncogenic stress) 
[8]. OIS is a major barrier against cancer transformation (Braig et al., 2005; Lin et 
al., 1998) and therefore overcoming OIS is a critical step in tumorigenesis (Sage 
et al., 2003). Activation of this process is largely dependent on p53 (Lin et al., 
1998; Serrano et al., 1997), and consequently its bypass by cancer cells is mainly 
achieved by emergence of somatic mutations in p53 or other components of its 
pathway (Korkmaz et al., 2016; Smogorzewska and de Lange, 2002). As p53 is 
an enhancer binding transcription factor (TF), whose function in transcriptional 
regulation is required for its tumor suppressive activity, we previously performed 
a CRISPR-based functional genomic screen that systematically targeted p53-
bound enhancers(Melo et al., 2013). That screen uncovered several p53-bound 
regulatory elements that are required for the activation of OIS. However, aberrant 
expression of oncogenes can lead to activation of additional transcription factors 
(TFs) whose function is also critical for the establishment and/or maintenance of 
OIS. In the current study, we aimed at the identification of such TFs and discovery 
of additional enhancers that are required for the establishment of OIS. We carried 
out an unbiased profiling of enhancers activated upon oncogenic stress, which 
indicated AP-1 as a major regulator of the transcriptional program induced by OIS. 
We thus generated a CRISPR-Cas9 sgRNA library designed to target enhancers 
putatively regulated by AP-1, and used it in a functional screen to identify those 
required for OIS. This screen detected EnhAP1-OIS1, an AP-1 bound enhancer that is 
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hyper-activated in OIS and whose abrogation results in OIS bypass. Furthermore, 
we identifi ed FOXF1 as the target gene of this enhancer, and demonstrated that it 
regulates the senescence phenotype.
Results
Genome-wide identifi cation of OIS-induced enhancers
We previously carried out a CRISPR-based screen aimed at identifi cation of p53-
bound enhancers that are required for OIS(Korkmaz et al., 2016). That screen was 
confi ned to regions that are directly bound by p53 as detected by p53 ChIP-seq 
analysis, and therefore missed enhancers that are critical for OIS enforcement and 
are regulated by other TFs, in either p53-dependent or independent manner. To 
overcome this limitation and to globally screen DNA regulatory elements activated 
by OIS without being biased by preselection of a candidate TF, we fi rst sought 
to comprehensively detect all the enhancers that are activated upon oncogenic 
stress. To this goal we utilized Global Run-On sequencing (GRO-seq), a nascent RNA 
detection method (Core et al., 2008), that allow robust determination of eRNA 
expression, as a quantitative measure for enhancer activity (Kim et al., 2010; Melo 
et al., 2013; de Santa et al., 2010). We used a cellular system in which the oncogene 
RASG12V was induced in hTERT-immortalized BJ cells (BJ-indRASG12V). As these cells 
contain wild-type p53, oncogenic stress results in a very potent activation of OIS 
and proliferation arrest (Drost et al., 2010). Exploiting bi-directional transcription 
as a hallmark of transcriptional activity at enhancers and promoters (Kim et 
al., 2010; Melgar et al., 2011; Wang et al., 2011), we detected 1,821 regulatory 
elements whose activity was induced in BJ-indRASG12V upon oncogene induction 
for 14 days (Fig. 1A; Table S1). Next, we bioinformatically searched for TFs that 
potentially mediate the activation of these regions by performing de novo DNA 
motif enrichment analysis. Remarkably, we found that the regulatory regions 
activated during the induction of OIS were signifi cantly enriched for the binding 
motif of the AP1 (FOS:JUN) transcription factor (TF)  (Fig. 1B). Overall, these 
results suggest an important role for AP1 in the regulation of the transcriptional 
response to oncogenic stress.
Therefore, we constructed a CRISPR library that systematically targets OIS-
induced DNA elements that are putatively regulated by AP1, and performed a 
functional genetic screen to identify those that are required for OIS activation. 
The de novo motif analysis detected 762 AP1 motifs in 638 OIS-induced regulatory 
elements (over-representation p-value=1.2*10-88). We examined which of these 
motif occurrences can be targeted by CRISPR-Cas9, given the requirement for the 
presence of the NGG PAM motif near the AP-1 motif. WE required that the Cas9-
madiated DNA cut will occur either within the motif itself or up to a margin of 5 nt 
with respect to it (Fig. 1C). 398 (62%) of the 638 OIS-induced regulatory elements 
(REs) containing AP1 motif met this criterion, with most motifs targeted by 2-3 
distinct sgRNAs. Accordingly, we designed 840 sgRNAs that target AP1 motifs 
in 398 OIS-induced regulatory elements. We cloned these sgRNAs as a pool into 
pLentiCRISPRv2 vector, and generated a plasmid library referred herein as CRISPR-
AP1-EnhLib (Fig. 1D and Table S2).
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Figure 1. Design of a CRISPR screen targeting AP1 enhancers which are activated upon 
oncogenic stress. 
A. An example of an enhancer whose activity is induced in response to oncogenic stress. Enhancer activity 
is inferred from the typical bi-directional transcription of eRNAs (BJ+DMSO indicates proliferating cells, 
and BJ+4-OHT indicates senescent cells); Genomic regions that show DNase hypersensitivity (DHS), as 
determined by ENCODE, are shown by the grey track). Overall, our GRO-seq analysis identifi ed 1,821 
regulatory elements (REs; enhancers or promoters) whose activity was induced in BJ cells in face of 
RAS activation. B. De novo motif analysis detected highly signifi cant enrichment of the FOS:JUN (AP1) 
DNA motif in the regulatory elements that were induced upon oncogenic stress. Top – the enriched 
motif detected in our dataset; bottom – the AP1 motif from the JASPAR DB [49]. C. An example for 
occurrence of an AP1 motif within an enhancer that was induced upon oncogenic stress, that is located 
close enough to an NGG PAM motif, resulting in Cas9-mediated DNA cleavage that occur within the 
motif (Cas9 cleavage occurs ~3 nt before the PAM). Overall, we identifi ed 398 induced REs with AP1 
motif that met this requirement (Cas9 cleavage within a margin of 5 nt with respect to the motif). D. 
Statistical summary of the CRISPR-AP1-EnhLib used in our functional screen.
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CRISPR screen targeting OIS-induced enhancers with AP-1 motif
We used the CRISPR-AP1-EnhLib library to screen for DNA elements that are 
putatively regulated by AP1 and are required for the activation of OIS. BJ-
indRASG12V were transduced with four independent lentiviral pools of CRISPR-
AP1-EnhLib and selected with puromycin. Then we treated the cells with 4-OHT 
(RAS induction) or DMSO (control) as shown in Figure 2A. Following four weeks 
of culturing, we harvested the cells, isolated genomic DNA, amplifi ed integrated 
vectors by PCR, and used next-generation sequencing (NGS) to quantify the 
abundance of integrated sgRNAs present in each population. We reasoned that 
sgRNAs targeting regulatory elements that are required for OIS would cause 
bypass of senescence, sustained cell proliferation, and thus would be enriched 
in the cell population under oncogenic stress compared to control (Fig. 2A). 
Indeed, our screen detected several sgRNAs that were highly enriched in the OIS 
population (Fig. 2B; Table S3), among them, fi ve showed an average enrichment 
fold above 1.75 over the four replicates of the screen. Notably, two of these fi ve 
sgRNAs, sgRNAs-AP169 and sgRNA-AP171, are independent sgRNAs that target the 
same enhancer region (Fig. 2B), hence increasing the confi dence that these are 
true positive hits. ENCODE ChIP-seq data confi rmed a strong binding of both FOS 
and JUN to this region (Figure S1). Moreover, our GRO-seq data showed ~2-fold 
induction of eRNA expression from this enhancer in response to oncogenic stress. 
Thus, we selected this regulatory region for further validation and functional 
characterization and named it EnhAP1-OIS1.
First, using individual transductions, we validated that the introduction of sgRNAs 
AP169 and AP171 to BJ-indRASG12V cells causes a potent bypass of OIS, as judged by 
cell number and morphology (Fig. 2C). Second, we confi rmed that introduction 
of these two sgRNAs to BJ-indRASG12V cells indeed results in an array of small 
deletions and insertions at the expected position within the AP1 binding motif in 
the targeted enhancer (Figure S2). Third, following induction of oncogenic stress, 
sgRNAs AP169 and AP171 transduced BJ-indRASG12V cells showed a signifi cant 
reduction in senescent-associated-β-Gal (SA-β-Gal) staining (Fig. 2D, Figure 
S3) and an elevated BrdU staining (Fig. 2E, Figure S3), indicative of attenuated 
activation of cellular senescence and of sustained cellular proliferation compared 
to the NT control. As expected, while the eff ect caused by these two sgRNAs was 
highly signifi cant, it was not as strong as the eff ect elicited by targeting p53 (Fig. 
2D-E). Last, we examined the activity of EnhAP1-OIS1 following the transduction of 
sgRNAs AP169 and AP171 by measuring eRNA expression at the EnhAP1-OIS1 locus. As 
expected, targeting EnhAP1-OIS1 by these two sgRNAs signifi cantly compromised its 
activity during OIS compared to the control sgRNA (Fig. 2F).
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Figure 2. Functional CRISPR screen discover a novel enhancer required for OIS. 
A. Schematic representation of the set-up of our functional screen. B. Results of the CRISPR screen. 
sgRNAs are sorted by the enrichment score based on the ratio between their prevalence in the BJ+4-
OHT and BJ +DMSO control populations (measured 4 weeks after 4-OHT treatment). Y-axis shows 
Z scores of the mean sgRNA enrichment scores (calculated over the four replicates of the screen). 
Coloured in red are two sgRNAs, sgRNA-AP169 and sgRNA-AP171, that target the same enhancer, called 
here EnhAP1-OIS1 C. Individual transductions of sgRNA- AP169 and sgRNA-AP171 validated that they cause 
OIS bypass. sgRNA targeting p53 was used as a positive control and a non-targeting (NT) sgRNA was 
used as a negative control. D. Targeting EnhAP1-OIS1 by either sgRNA- AP169 or sgRNA-AP171 caused 
OIS bypass as measured by β-gal staining, a canonical mark for senescence (p53ko used as a positive 
control). Data shown represents mean (SD), n=4. *p<0.05. E. Targeting EnhAP1-OIS1 by either sgRNA- AP169
or sgRNA-AP171 resulted in enhanced proliferation as measured by BrdU staining (p53ko used as a 
positive control). 
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Data shown represents mean (SD), n=4. *p<0.05. F. Measurement of eRNA production at EnhAP1-OIS1 in 
cells with the indicated sgRNAs. eRNA levels are significantly decreased upon mutagenesis of the AP1 
binding site caused by either sgRNA- AP169 or sgRNA-AP171. Data shown represents mean (SD), n=3. 
*p<0.05. G. BJ-indRASG12V cells were transfected with the indicated plasmids, and treated with DMSO 
or 4-OHT for 72h. pGL3 constructs contain firefly luciferase reporter gene with the corresponding 
enhancer (none for pGL3-promoter, two different orientations for EnhAP1-OIS1). Relative luciferase 
activity is calculated by dividing the firefly luciferase activity to that of Renilla luciferase. Normalized 
luciferase activity is calculated by dividing the relative luciferase activity to that of pGL3-promoter for 
each condition. Data shown represents mean (SD), n=6. *p<0.05. H. BJ-indRASG12V cells were transfected 
with the indicated enhancer constructs. Endogenous motif represents the original sequence of EnhAP1-
OIS1, in vitro mutation construct represents mutagenesis of the AP1 consensus motif, and MU44835851 
represents mutant construct bearing a C>A mutation as indicated. The cells were treated with 4-OHT 
for 48h prior transfections. Data shown represents mean (SD), n=3. *p<0.05.
Next, we carried out in vitro reporter assays to verify that EnhAP1-OIS1 functions 
as enhancer and promotes transcription of target genes. We cloned EnhAP1-OIS1 
downstream of the Firefly luciferase gene in two orientations in pGL3-promoter 
vector followed by transfection into BJ-indRASG12V cells. While we did not observe 
a noticeable elevation of luciferase activity in cells treated with DMSO, there was 
a significant increase of 3-fold in cells treated with 4-OHT (Fig. 2G). To verify that 
mutations in the AP1 binding site disrupts the enhancer activity as we observed 
in sgRNA-AP169/71 cells, we mutated the AP1 motif of EnhAP1-OIS1 and examined 
the effect on the enhancer activity, in condition of oncogenic stress. Indeed, the 
mutations completely abolished the ability of EnhAP1-OIS1 to stimulate luciferase 
expression (Fig. 2H).  In addition, we searched for tumor somatic mutations within 
the AP1 binding motif (using ICGC data), and found one case in a lung cancer 
patient (Figure S4). The mutation is a C to A substitution within the consensus 
motif of AP1, and located at the cut site of sgRNA-AP169. To examine if this somatic 
mutation disrupts the activity of EnhAP1-OIS1, we performed mutagenesis of EnhAP1-
OIS1 on the reporter construct with a single nucleotide substitution. Remarkably, we 
observed a 50% reduction of the enhanced luciferase activity (Fig. 2H), suggesting 
an important role of the specified nucleotide in determining binding affinity of AP1 
to this enhancer. Taken together, our functional genetic screen and subsequent 
focused experiments have identified and validated a novel AP1-bound enhancer 
whose activity is required for proper induction of OIS.
FoxF1 is a target gene of EnhAP1-OIS1
Next, we set up experiments to elucidate the mode of action by which EnhAP1-OIS1 is 
required for OIS. Enhancers regulate gene expression of cis-located target genes 
that can reside hundreds of kbp away. Examination of our GRO-seq data indicated 
that FOXF1, the nearest gene to the EnhAP1-OIS1 locus (located >100 kbp downstream 
of it), was ~2 fold induced following oncogenic stress (Fig. 3A), suggesting a 
potential functional connection. No other gene in a 1 Mbp distance from EnhAP1-
OIS1 showed such a strong effect. Furthermore, we performed RNA-seq with 
cells transduced with sgRNA-AP169 and sgRNA-AP171, and observed a significant 
reduction in the expression of FOXF1 (Figure S5). We validated this result using 
qRT-PCR analysis, which also indicated that targeting EnhAP1-OIS1 by either sgRNA-
AP169 or sgRNA-AP171 results in a significant reduction in the expression level of 
FOXF1 under OIS conditions (Fig. 3B). Western blotting analysis confirmed this 
result at the protein level, in addition to confirming that FOXF1 expression is 
increased following oncogenic stress (Fig. 3C). Publicly available RNA Pol II ChIA-
PET data (from Hela cells) indicate physical interaction between EnhAP1-OIS1 and the 
3’ region of FOXF1 (Figure S6), which was confirmed in the chromatin conformation 
capture (3C) experiments of senescent BJ cells (Figure S7). More importantly, the 
physical interactions between EnhAP1-OIS1 and the promoter region of FOXF1 were 
significantly stronger (Figure S7), suggesting a robust transcriptional regulation 
of EnhAP1-OIS1.  Collectively, these results strongly point to FOXF1 as the target gene 
of EnhAP1-OIS1.
Chapter 4 Functional CRISPR Screen Identiﬁ es AP1-associated Enhancer
4
8786
0
0.5
1.0
1.5
* *
NT AP169 AP171sgRNA:
Re
la
ti
ve
 F
ox
F1
 m
R
N
A
 e
xp
re
ss
io
n
A
B C
D E
FENDRR
FENDRR
FOXF140 _
0 _
40 _
40 _
0 _
40 _
100 _
0 _
50 _
0 _50 _
0 _
BJ+DMSO
BJ+TAM
H3K27Ac
H3K4Me1
H3K4Me3
UCSC genes
EnhAP1-OIS1
+4OHT+DMSO
NTsgRNA
HSP90
p21
HRas
ER-HRas
FoxF1
AP169 AP171 FoxF1 NT AP169 AP171 FoxF1
0
10
20
30
40
50
* *
0
20
40
60
80
* *
Figure 3
β-
ga
l p
os
iti
ve
 c
el
ls
 %
B
rd
U
 p
os
iti
ve
 c
el
ls
 %
+4OHT
NT FOXF1 p53sgRNA:
HSP90
p21
H-Ras
+TAM+DMSO
NTsgRNA AP169 AP171 FoxF1 NT AP169 AP171 FoxF1 p53
Figure S6
NT FOXF1 p53sgRNA:
50 kb hg19
86,420,000 86,430,000 86,440,000 86,450,000 86,460,000 86,470,000 86,480,000 86,490,000 86,500,000 86,510,000 86,520,000 86,530,000 86,540,000 86,550,000
Scale
chr16:
Figure 3. FOXF1 is the target gene regulated by EnhAP1-OIS1.
A. UCSC screenshot of GRO-seq analysis of BJ-indRASG12V cells. BJ cells were treated with DMSO or 
4-OHT for 14 days. Bidirectional transcription is represented by using positive and negative values for 
expression in the Crick and Watson strands, respectively. The genomic regions of EnhAP1-OIS1 and FOXF1
are enlarged. Note the enhancement in GRO-seq signal for both EnhAP1-OIS1 and FOXF1 in BJ+4-OHT 
(brown track) compared to BJ+DMSO (blue track). B. mRNA levels of FOXF1 are reduced in sgRNA-
AP169 and sgRNA-AP171 targeted cells under 4-OHT treatment. Data shown represents mean (SD), 
n=3. *p<0.05. C. BJ-indRASG12V cells transduced with the specifi ed sgRNAs were treated with DMSO or 
4-OHT for 14 days, and FOXF1, p21, and HRas protein levels were measured by western blot. HSP90 
was used as the loading control. The band of FOXF1 is marked with an arrow. ER-HRas indicates the 
induced version of HRas. D. Targeting the FOXF1 and p53 genes caused OIS bypass as measured by β-gal 
staining. Note the stronger eff ect of FOXF1ko compared to the eff ect elicited by targeting EnhAP1-OIS1
(Fig. 2D). Data shown represents mean (SD), n=4. *p<0.05. E. Targeting FOXF1 and p53 gene resulted in 
enhanced proliferation as measured by BrdU staining. Data shown represents mean (SD), n=4. *p<0.05.
Loss of FOXF1 causes senescence bypass and abolishes senescence 
expression signatures
To further establish FOXF1 as the target gene that links EnhAP1-OIS1 to senescence, we 
examined the phenotypic eff ect of knocking out FOXF1. Indeed, targeting FOXF1
results in a strong senescence bypass phenotype, as evident by signifi cant reduction 
in SA-β-Gal staining (Fig. 3D) and elevated BrdU staining (Fig. 3E), similar to the 
eff ect elicited by targeting EnhAP1-OIS1 (Fig. 2E-F). Eff ective FOXF1 knockout was 
confi rmed by western blotting analysis (Fig. 3C). Last, we used RNA-seq to globally 
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Figure 4. EnhAP1-OIS1 and FOXF1 knockouts display expression profi les of senescence 
bypass.  
GSEA analysis of expression profi les measured in 4OHT-treated BJ-indRASG12V cells targeted by sgRNA-
AP169, sgRNA-AP171, or sgRNA-FOXF1 compared to the profi le of control 4OH-treated cells transduced 
with non-targeting sgRNA. A list of shared genes within each group is shown. 
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compare expression profi les in BJ-indRASG12V cells transduced with either sgRNAs 
targeting EnhAP1-OIS1 (sgRNA-AP169 or sgRNA-AP171), sgRNA targeting FOXF1, or 
a control non-targeting sgRNA. GSEA analysis (Subramanian et al., 2005) for 
functional characterization of the biological processes aff ected by these genetic 
manipulations showed that cell-cycle genes and genes encoding ribosomal proteins 
are signifi cantly up-regulated when targeting either EnhAP1-OIS1 or FOXF1, refl ecting 
the bypass of OIS and the subsequent enhanced proliferation experienced by 
these cells following oncogene hyperactivity (Fig. 4). Conversely, the induction of 
various extra cellular matrix (ECM) components that is exhibited in OIS was largely 
attenuated in cells with EnhAP1-OIS1 or FOXF1 knockouts (Fig. 4). Taken together, 
our results strongly indicate that EnhAP1-OIS1 controls OIS through the regulation of 
FOXF1 expression (Fig. 5).
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Figure 5. Model of EnhAP1-OIS1 regulation of OIS. 
A. In normal BJ fi broblast cells, hyper-activation of RAS induces MAPK signaling cascade, including AP-1 
TFs. Activated AP-1 TFs control diff erent cellular functions, including cell proliferation and apoptosis. 
AP1 is recruited, among other enhancers, to EnhAP1-OIS1 and stimulates its activity. This in turn promotes 
the expression of the target gene FOXF1, diverting oncogenic signals into pre-senescent pathway. B. 
Mutagenesis of the AP-1 binding site in EnhAP1-OIS1 abrogates its enhancer activity and thus leading to 
decreased expression of FOXF1. This results in compromised induction of OIS and thus cells continue 
uncontrolled cell proliferation.
Discussion
In this study, we fi rst found that OIS-induced enhancers are enriched for the binding 
motif of AP1. Based on this fi nding, we perform a CRISPR screen focused on AP1 
motifs within enhancers that are activated upon oncogenic stress. We discovered 
a novel AP-1 bound enhancer, EnhAP1-OIS1, that is required for establishment of OIS 
and identifi ed FOXF1 as the target that mediates this role. We propose a new role 
of AP1 in senescence via activation of FOXF1, providing an additional regulation of 
cell proliferation during senescence.
AP1 TFs are recruited to enhancer regions to drive oncogenic growth (Zanconato et 
al., 2015) and are broadly required for enhancer selection(Vierbuchen et al., 2017), 
suggesting a possible role of AP1 at enhancers. As a downstream target of RAS 
signalling pathway, AP1 is activated to target mitogen-responsive genes (Deng 
and Karin, 1994; Kampfer et al., 1998). Earlier studies have shown that mRNA level 
and activity of AP1 genes are attenuated upon entering replicative senescence 
(Irving et al., 1992; Seshadri and Campisi, 1990). Altered AP1 activity is mainly due 
to loss of c-FOS expression and maintained JUN proteins, thus promoting JUN-
JUN homodimers instead of FOS-JUN heterodimers (Irving et al., 1992; Riabowol 
et al., 1992). This suggests that loss of AP1 activity is possibly responsible for the 
irreversible growth arrest in senescent cells. Conversely, overexpression of c-FOS 
with increased AP1 activity is not suffi  cient to initiate DNA synthesis in senescent 
human fi broblasts (Rose et al., 1992). Therefore, AP1 is likely not the key factor 
that regulates senescence, but rather a downstream factor that fi ne-tune the 
senescence program under replicative stress (e.g. H-RAS activation). In addition, 
previous functional genetic screens did not indicate any of the AP1 family members 
as critical factors in OIS(Burrows et al., 2010; Drost et al., 2010). Supporting this 
conclusion, CRISPR-mediated KOs of c-FOS and c-JUN did not result in any obvious 
bypass of OIS (Figure S8). However, it is possible that one or few targets of AP1 
mediate OIS while others antagonize it, or are required for cell survival.
FOXF1 belongs to the Forkhead family of transcription factors. FOXA1 has been 
reported to promote senescence via activation of p16INK4a (Li et al., 2013), and 
FOXO4 inhibition induces p53 nuclear exclusion, which results in apoptosis of 
senescent cells (Baar et al., 2017). The functions of FOXF1 remain to be determined, 
yet recent studies have implicated its role in lung regeneration by targeting genes 
of extracellular matrix and cell cycle progression (Bolte et al., 2017), as well as 
promoting prostate cancer growth via MAPK pathway (Fulford et al., 2016). To 
date, there has been no evidences of any connections between AP1, FOXF1 and 
OIS, possibly due to regulation via enhancers, rather than proximal promoters, as 
proposed in this study. It has been proposed that FOXF1 is a target gene of p53, 
which regulates cell migration and invasion (Tamura et al., 2014); and that FOXF1 
is a potential oncogene, which promotes rhabdomyosarcoma by repressing p21Cip1
(Milewski et al., 2017). Here we provide the fi rst evidence suggesting that FOXF1 is 
a potential tumour suppressor, regulating senescence in human cells. In addition, 
we generated double knockout cell lines (NT+p53 ko, sgRNA-AP169+ p53 ko, sgRNA-
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AP171+ p53 ko, and FOXF1 ko + p53 ko), and we observed a strong senescence 
bypass phenotype (Figure S9A-B). Interestingly, we found an additive effect of 
proliferation in the EnhAP1-OIS1 ko and FOXF1 ko cell lines (sgRNA-AP169+ p53 
ko, sgRNA-AP171+ p53 ko, and FOXF1 ko + p53 ko) compared with NT + p53 ko cells 
(Figure S9B). This suggests that FOXF1 regulates OIS in a p53 independent manner. 
In parallel with the canonical p53 pathway, FOXF1 regulates the expression of a 
subset of cell cycle and ribosomal genes (Fig. 4). Further studies should explore 
the exact function of FOXF1 in regulating senescence.
We propose a model in which following oncogenic induction, AP1 TFs are activated 
to promote cellular proliferation in response to stimuli. However, under excessive 
exposure to RAS, AP1 is recruited to EnhAP1-OIS1 to promote the expression of 
FOXF1 to drive cells into senescence. Disruption of the AP1 binding site within 
EnhAP1-OIS1 results in attenuated activation of FOXF1, hampering full execution of 
the OIS program. We attempted to generate a FOXF1 overexpression cell line 
while targeting EnhAP1-OIS1, to rescue the senescence phenotype. However, this was 
not successful, possibly due to the intolerance of the cells under ectopic FOXF1 
expression. This result show that although AP1 is activated by MAPK pathway, and 
stimulates the expression of many cell cycle genes, upon oncogenic stress it also 
mediates tumor suppressive effects.
Our current knowledge on cancer driver non-coding somatic mutations (SMs) is 
still very rudimentary, yet several studies suggested that the role of such SMs 
is underappreciated(Melton et al., 2015; Weinhold et al., 2014). Genome-wide 
analysis has revealed AP1 as a key factor at regulatory elements in cancers(Davie 
et al., 2015), and AP1 binding sites are frequently mutated in various cancer types 
(Kaiser et al., 2016). Analysing ICGC data, we found a somatic mutation within 
the AP1 motif of EnhAP1-OIS1 in a lung cancer patient, and validated its functional 
effect by using in vitro reporter assays (Fig. 2H). This suggests a possible cancer 
driver effect for somatic mutations in AP1 binding motifs. Our study further 
demonstrates the power of CRISPR-based screens in exploring the function of the 
noncoding genome.
Conclusions
Our study provides evidence that AP1 TFs are broadly stimulated during OIS and 
are localized to enhancer regions to activate specific gene programs. We show 
that AP1 controls senescence program via EnhAP1-OIS1 and its target gene FOXF1. 
We propose that AP1 is a double-edged sword in regulating cell proliferation and 
senescence, providing a restrictive feedback on unlimited cell proliferation. 
Methods
Cell culture
BJ/ET/RasV12and HEK293-T cells were cultured in DMEM medium (Gibco), 
supplemented with 1% penicillin/streptomycin (Gibco) and 10% FCS (Hyclone). To 
induce OIS, BJ cells were treated with 100 nM 4-OHT (Sigma) for 14days.
Analysis of GRO-seq data
GRO-seq was applied to control and RASG12V-induced hTERT immortalized BJ cells 
(14 days after RAS induction). These conditions were probed using biological 
duplicates. Sequenced reads were aligned to the human genome (hg19) using 
bowtie2 (Langmead and Salzberg, 2012). Transcriptional units (TUs) were inferred 
from the GRO-seq data using HOMER (Heinz et al., 2010). Read counts per TU were 
calculated using HTseq-count (Anders et al., 2015). 76,200 TUs covered by at least 
20 reads in at least one sample were detected. TU expression levels were than 
normalized using quantile normalization to allow comparison between samples, 
and fold-change (FC; presented in log2 base) were calculated between the RAS-
induced and control samples. To avoid inflation of high FC value for lowly expressed 
TUs, we set a floor value of 10 (that is, all expression levels below 10 were set to 
10). Next, we defined bi-directional TUs as TUs whose start site is separated by 
no more than 800 bp and are transcribed on opposite strands (TU+ and TU-). As 
bi-directional transcription is a hallmark of transcriptional regulatory elements, 
we refer to these loci as regulatory elements (REs). Overall, this analysis defined 
36,497 regulatory elements. Last, a regulatory element (bi-directional TU) was 
defined as OIS-induced if the expression level of both its mates was elevated by 
at least 2-folds upon RAS induction, in both duplicates. In total, 1,821 OIS-induced 
REs were identified in our dataset (Table S1).
Motif enrichment analysis
The sequences of the OIS-induced regulatory elements were searched for 
statistically over-represented TF binding motifs. We performed this de novo motif 
analysis using DREME (Bailey, 2011). For each bi-directional TUs, we scanned the 
region between the start site of the opposite mates (TU+ and TU-) plus a margin of 
200 bp to each direction. As control sequences, we extracted adjacent sequences 
of the same length are immediately upstream and downstream the test sequence. 
The binding motif of JUN/FOS was highly enriched (p=1.2*10-88) on the OIS-induced 
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REs. Specific occurrences of the enriched JUN/FOS motif were identified using 
FIMO with default parameters (Grant et al., 2011). Overall, 762 JUN/FOS motif 
occurrences were found on 638 OIS-induced REs.
CRISPR library construction and analysis
We designed a CRISPR library to target the FOS/JUN motifs in the OIS-induced REs. 
For 398 of the 638 OIS-induced REs with FOS/JUN motif, we found an occurrence of 
the NGG PAM in a location that is expected to induce a Cas9 DNA cleavage within a 
margin of 5 bp with respect to the motif (that is, the cut is expected to occur within 
the motif or up to 5 bp from its edges). Overall, we designed 840 distinct sgRNAs, 
collectively targeting FOS/JUN motif in 398 OIS-induced REs. We cloned these 
sgRNAs into pLentiCRISPRv2 vector and generated a plasmid library (which we 
call CRISPR-AP1-EnhLib). Induced and control BJ-indRASG12V were transduced with 
four independent lentiviral pools of CRISPR-AP1-EnhLib. Following four weeks of 
culturing, we harvested library-transduced cells, isolated genomic DNA, amplified 
integrated vectors by PCR, and used next-generation sequencing (NGS) to quantify 
the abundance of integrated sgRNAs present in each population. Read counts were 
normalized to 1M reads and enrichment ratio (fold-change in log2) were calculated 
for each sgRNA between the induced and control samples per replicate. (To avoid 
inflation of FC for sgRNAs covered by low number of reads, counts bellow 50 were 
set to 50). Next, average enrichment factor was calculated per sgRNA over the 
four replicates and was transformed to a Z score (Fig. 2B, Table S3).
Senescence-associated b-galactosidase assay
BJ cells were transduced with different sgRNA constructs and selected with 
puromycin. After selection, cells were seeded in triplicate in 6-well plates and 
treated with 100 nM 4-OHT for 14 days. β-galactosidase measurement was 
performed by following the protocol of the Senescence β-Galactosidase Staining 
Kit (Cell Signaling), and at least 1000 cells were analyzed for each condition.
BrdU proliferation assay
BJ cells were seeded in 6-well plates on day 1. Next morning, cells were incubated 
in fresh medium for 3 h with 30 µM bromodeoxyuridine (BrdU, Sigma) followed by 
two times PBS wash and then fixed with 4% formaldehyde. Cells were washed two 
times with PBS and treated with 5M HCl/0.5% Triton to denature DNA. Cells were 
neutralized with 0.1M Na2B4O7. The cells were then treated with blocking buffer 
(3% BSA in 0.5% Tween PBS) for 30min and incubated with anti-BrdU antibody 
(Dako) with blocking buffer for 2 hours at room temperature. Cells were washed 
with PBS three times, and finally incubated with FITC-conjugated anti-mouse Alexa 
Fluor 488 secondary antibody (Dako) in blocking buffer for 1 hour, washed three 
times, stained with propidium iodide for 30min. BrdU incorporation was measured 
by immunofluorescence (at least 1000 cells were scored for each condition). The 
numbers of individual nucleus and BrdU-stained nucleus were counted using 
imageJ software.
Luciferase reporter assay
The constructs with the enhancers were cloned based on pGL3-promoter 
(Promega) vector. The enhancer region was PCR amplified from BJ genomic DNA 
and inserted downstream of the firefly luciferase reporter gene. The transfection 
was performed by seeding 1x105 of cultured cells in 6-well plates. The next day, 
500ng of each construct (pGL3-promoter, pGL3-EnhAP1-OIS1-Fw, and pGL3-EnhAP1-
OIS1-Rv) were co-transfected with 50ng of Renilla luciferase reporter construct 
using Fugene-6 (Promega) following manufacturer’s protocol. Luciferase reporter 
assay was performed 24h post transfection using Dual-Luciferase Reporter assay 
kit (Promega). Cells were lysed directly on the plate with passive lysis buffer for 
15min at room temperature. Firefly and Renilla luciferase activity was measured 
with the substrates from the kit using Centro XS3 LB960 machine (Berthold 
technologies). For BJ-indRASG12V, cells were pre-treated with 100nM 4-OHT for 
48h prior transfection. For HCT116, cells were treated with UV-C (50J/m2) or 
MG132 (5µM) 18h after transfection. The luciferase assay was performed 5h post 
treatment.
Mutagenesis of EnhAP1-OIS1
Mutations of EnhAP1-OIS1 were performed using QuikChange Lightning site-directed 
mutagenesis kit (Agilent) according to the manufacture’s manual. Briefly, primers 
for mutagenesis were designed using the online tool from Agilent. pGL3-EnhAP1-
OIS1-Fw and pGL3-EnhAP1-OIS1-Rv were PCR amplified and transformed into DH5α 
bacteria. Single colonies from each mutant were sequence verified and used for 
transfection.
RNA isolation, reverse transcription and qRT-PCR
Total RNA was extracted by using TRIsure (Bioline) reagent and following the 
manufacturer’s protocol. Reverse transcription was done with SuperScript III 
(Invitrogen) using 1 µg of total RNA per reaction. qRT-PCR reaction was performed 
using SensiFAST SYBR No-ROX Kit (Bioline) in LightCycler 480 (Roche). Primers 
used are listed in Table S4.
Western blot
1x106 Cells were seeded in 10cm dish and treated with DMSO or 4-OHT for 14 days. 
Cells were trypsinized and cell pellets were lysed with RIPA buffer supplemented 
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with 1x cOmplete protease inhibitor cocktail (Roche) following the manufacturer’s 
protocol. Protein concentrations were determined using Pierce BCA protein assay 
kit (Thermo Scientific). Lysates were separated on SDS-PAGE gels and transferred 
Membranes were immunoblotted with the following antibodies: CDKN1A (Sc-397, 
Santa Cruz; 1: 1,000), HRAS (C-20, Santa Cruz; 1: 1,000), FoxF1 (ab168383, Abcam, 
1:1000), HSP90 (610418, BD biosciences, 1:3000). Protein bands were visualized 
using corresponding secondary antibodies (Dako) and ECL reagent (GE Healthcare).
Lentiviruses production and infection
HEK293T cells were seeded at the density of 5 X 106 cells per 10cm dish one day 
prior transfection. Transfection was performed using PEI (Polyethylenimine, 
Polysciences) and medium was refreshed after 16h. Virus-containing supernatant 
was collected 48h post transfection by filtering through a 0.45 µm membrane 
(Milipore Steriflip HV/PVDF) and snap-frozen, stored at −80°C. BJ cells were 
infected and selected with the proper antibiotics 48 h after transduction for at 
least 4 days until no surviving cells remained in the no-transduction control plate.
Chromatin Conformation Capture (3C) analysis
10 x 106 cells were harvested in PBS for each 3C sample. Cells were centrifuged at 
300xg for 5min at RT, and resuspended PBS / 10% FBS. Then cells were incubated with 
equal volume of 4% formaldehyde (2% end concentration) for 10min and quenched 
with 2M glycine solution (0.2M end concentration), followed by centrifugation at 
300xg for 5min at 4oC. Cell pellet was then resuspended in PBS / 10% PBS and 
centrifuged at 300xg for 5min at 4oC. The supernatant was then discarded and 
snap-frozen, stored at -80oC. The cell pellet was lysed in 3mL lysis buffer (50mM 
Tris -HCl pH 7.5, 0.5% NP-40, 1% Triton X-100, 150mM NaCl, 5mM EDTA, protease 
inhibitor cocktail (Roche)) for 1.5h at 4oC, followed by centrifugation at 1000xg for 
3min. The pellet was washed once in 1.2x restriction buffer and resuspended again 
in 500µL of 1.2x restriction buffer. 15µL of 10% SDS was added to the suspension 
and incubated at 37oC while shaking at 400rpm. 75µL of 20% Triton X-100 was 
added to the suspension and incubated at 37oC while shaking at 400rpm. The 
samples were then centrifuged at 1000 x g for 3min and resuspended in 500µL of 
1x restriction buffer. The digestion was performed with addition of 200U of Csp6I 
(Thermo Fisher Scientific) at 37oC overnight. The digestion efficiency was assessed 
the next day on agarose gel. The enzyme was then inactivated at 65oC for 20min 
and then samples were centrifuged at 1000 x g for 3min to remove the restriction 
buffer. The pellet was resuspended in 7mL of 1x ligation buffer, and the ligation 
was performed with addition of 50U of T4 DNA ligase at 16oC overnight. Again, the 
ligation efficiency was examined on agarose gel. De-crosslinking was performed 
by addition of 30µL of protease K (Roche) at 65oC overnight. To remove residual 
RNA, 15µL of RNaseA cocktail (Ambion) was added to the samples and incubated 
at 37oC for 45min. DNA was recovered by adding 7mL of isopropanol and 70µL of 
NucleoMag 96 PCR beads (Bioke) and incubated for 30min at room temperature. 
The samples were centrifuged for 3min at 1000 x g and washed with 80% ethanol 
twice. Finally, the beads were dried and eluted in 300µL of 10mM Tris-HCl pH 
7.5. To assess the physical interactions between EnhAP1-OIS1 and target regions, we 
designed a constant primer (C1) that amplify the EnhAP1-OIS1 region overlapping the 
junction created by Csp6I enzyme. For each assessed region, we designed two 
primers (reverse and forward) to examine the interactions with EnhAP1-OIS1. The 
first PCR was performed with primer C1 and each candidate primer for 25 cycles. 
Afterwards, a nested PCR was performed using a second constant primer (C2) and 
each candidate primer for another 18 cycles. Finally, PCR products were resolved 
on 2% agarose gel. To assess the primer efficiency, we PCR amplified the genomic 
regions of EnhAP1-OIS1 and FOXF1, and mixed equal molar of each fragments as the 
template. The template DNA was then digested and ligated as mentioned. Finally, 
the quantifications were normalized with the primer efficiencies. To examine 
the sequences of the PCR products, DNA bands were cut, isolated, and sanger-
sequenced. 
Mutation analysis of enhancer regions
Genomic DNA of the cells transduced with sgRNAs were isolated and quantified. 
500ng of the genomic DNA was used for PCR to amplify the enhancer region. We 
performed a two-step PCR by introducing the P5 adapter sequences in the first 
PCR and P7 adapters with the indexes in the second PCR. After the second PCR, 
the libraries were purified with CleanPCR beads (CleanNA) and quantified on 2100 
Bioanalyzer using a 7500 chip (Agilent). Equimolar of each sample was taken for 
the final library. Libraries were sequenced using the Mi-Seq platform. Sequenced 
reads were aligned to the amplified enhancer region using bowtie. Bam files were 
analysed to count the number of mutations (mismatches, insertions or deletions) 
identified at each location in that region.
RNA-seq library construction
Total RNA was isolated using Trisure reagent (Bioline) following the manufacturer’s 
protocol. Briefly, cells were lysed in Trisure, precipitated with isopropanol, and 
dissolved in RNase-free water. To generate strand-specific libraries, we used 
the TruSeq Stranded mRNA sample preparation kit (Illumina) following the 
manufacturer’s instructions. Briefly, 1000ng of total RNA was polyA-enriched 
using oligo-dT beads, and the RNA was fragmented, random primed and reverse 
transcribed using SuperScript II Reverse Transcriptase (Invitrogen). Second strand 
cDNA was then synthesized, 3’-adenylated and ligated to Illumina sequencing 
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adapters and subsequently amplified by 12 cycles of PCR. The sequencing libraries 
were analyzed on a 2100 Bioanalyzer using a 7500 chip (Agilent), and pooled 
equimolar into a 10nM multiplex sequencing pool.
Sequencing
Sequencing of the CRISPR screen and RNA-seq was done using single reads of 65bp 
on the Hi-Seq2500 platform (Illumina). Mutation analysis of enhancer regions were 
performed with single reads of 150bp on the Mi-Seq system with Mi-Seq reagent 
v2 Nano kit.
RNA-seq analysis
Gene expression profiles were recorded in BJ-indRASG12V (14 days after RAS 
induction by 4-OHT treatment) transduced with CRISPR vectors that either 
targeted the EnhAP1-OIS1 using sgRNA-AP169, sgRNA-AP171, targeted FOXF1 itself or 
transduced with a control non-targeting sgRNA (sgRNA-NT). Sequenced reads were 
aligned to the human genome (hg19) using TopHat2 (Kim et al., 2013). Number of 
reads mapped to each annotated gene was counted using HTseq-count (Anders et 
al., 2015), and then converted to RPKMs (using GENCODE v25 annotations). RPKM 
levels were further normalized using quantile normalization and expression levels 
in each sample relative to the control non-targeting sample were calculated (in 
log2 base). Biological pathways and processes affected by targeting the EnhAP1-OIS1 
or FOXF1 were sought using gene-set enrichment analysis (GSEA) (Subramanian et 
al., 2005).
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Figure S1. UCSC screenshot of EnhAP1-OIS1 with ENCODE CHIP-seq data.
ENCODE CHIP-seq data shows a signicant binding of c-Fos and c-Jun to EnhAP1-OIS1. The binding of
these factors coincides with the AP1 family consensus motif (Jun, JunD, and Fos in this case).
Figure S1. UCSC screenshot of EnhAP1-OIS1 with ENCODE CHIP-seq data. 
ENCODE CHIP-seq data shows a significant binding of c-Fos and c-Jun to EnhAP1-OIS1. The binding of these 
factors coincides with the AP1 family consensus motif (Jun, JunD, and Fos in this case).
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Figure S2. Mutation proles of BJ-indRASG12V cells transduced with sgRNA-AP169 and-AP171. 
Genomic DNA of BJ-indRASG12V cells with the indicated sgRNAs was isolated, and EnhAP1-OIS1 region was PCR 
amplied, subjected to deep sequencing and analysed for mutations. Proportion of wild-type or mutated 
(by mismatch, deletion or insertion) base calls is indicated as a function of its distance from the Cas9 
cleavage site. For sgRNA-AP169, the majority of the mutations are single nucleotide insertions, while for 
sgRNA-AP171 deletions around the cleavage site were more prevalent.
Figure S2. Mutation profiles of BJ-indRASG12V cells transduced with sgRNA-AP169  
and -AP171.
Genomic DNA of BJ-indRASG12V cells with the indicated sgRNAs was isolated, and EnhAP1-OIS1 region was 
PCR amplified, subject d to deep sequencing and analysed for mutation . Proporti n of wild-type or 
mutated (by mismatch, deletion or insertion) base calls is indicated as a function of its distance from 
the Cas9 cleavage site. For sgRNA-AP169, the majority of the mutations are single nucleotide insertions, 
while for sgRNA-AP171 deletions around the cleavage site were more prevalent.
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Figure S3. Representative pictures of β-Gal assay and BrdU staining. 
Representative pictures of β-Gal assay and BrdU staining experiments used for the analysis 
of the results shown in Fig. 2-3. Each column represents the cells infected with the indicated 
sgRNA. The cells were treated with 4-OHT for 14 days prior analysis. Upper panel shows the 
β-Gal staining experiments with senescent cells stained as blue. Lower panel shows the 
BrdU staining experiments with cells incorporated with BrdU stained as green and nucleus 
stained as red.
Figure S3. Representative ictures of β-Gal assay nd Br  stai ing.
A. Representative pictures of β-Gal assay and BrdU staining experiments used for the analysis of the 
results shown in Fig. 2-3. Each olumn repr sen s the cells infected with the indicated sgRNA. The cells 
were treated with 4-OHT for 14 days prior analysis. Upper panel shows the β-Gal staining experiments 
with senescent cells stained as blue. Lower panel shows the BrdU staining experiments with cells 
incorporated with BrdU stained as green and nucleus stained as red.
AP1 motif
Figure S4. Somatic mutation in the AP1 motif within EnhAP1-OIS1. 
Screenshots from ICGC portal show a single nucleotide substitution within the AP1 motif in 
EnhAP1-OIS1 detected in a patient with lung cancer.
Figure S4. Somatic mutation in the AP1 motif within EnhAP1-OIS1. 
Screenshots from ICGC portal show a single nucleotide substitution within the AP1 motif in EnhAP1-OIS1
detected in a patient with lung cancer.
FOXF1
Figure S5. RNA-seq analysis indicates FOXF1 as a target gene of EnhAP1-OIS1. 
Gene expression levels were measured in BJ cells targeted by either 
sgRNA-AP169, sgRNA-AP171 or sgRNA-NT negative control. Violin plots show 
the distribution of fold change of gene expression (in log2 base) calculated 
for the comparison between the sgRNA-AP169 and sgRNA-AP171 samples 
and the sgRNA-NT control. FOXF1 is marked by a rod dot. Its expression was 
markedly decreased by targeting EnhAP1-OIS1 by either sgRNA-AP169 or 
sgRNA-AP171.
Figure S5. RNA-seq analysis indicates FOXF1 as a target gene of EnhAP1-OIS1.
Gene expression levels were measured in BJ cells targeted by either sgRNA-AP169, sgRNA-AP171 or 
sgRNA-NT negative control. Violin plots show the distribution of fold change of gene expression (in 
log2 base) calculated for the comparison betw e  th  sgRNA-AP169 and sgRNA-AP171 samples and the 
sgRNA-NT control. FOXF1 is marked by a rod dot. Its expression was markedly decreased by targeting 
EnhAP1-OIS1 by either sgRNA-AP169 or sgRNA-AP171.
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Each CHIA-PET experiment is indicated with the name of cell lines and the antibody used for the pull down on 
the left. EnhAP1-OIS1 is highlighted in yellow and inferred physical interactions between two regions are presented 
by loops. Data is taken from the WashU epigenome browser [52].
Figure S6. RNA PolII ChIA-PET data support direct interaction between EnhAP1-OIS1 and 
FOXF1. 
Each CHIA-PET experiment is indicated with the name of cell lines and the antibody used for the pull 
down on the left. EnhAP1-OIS1 is highlighted in yellow and inferred physical interactions between two 
regions are presented by loops. Data is taken from the WashU epigenome browser [50].
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A. Genome browser presentation of the location of each primer used in 3C analysis. Constant primers (C1, C2) used 
to amplify EnhAP1-OIS1 are indicated in black arrows. Negative control regions with no interaction with EnhAP1-OIS1 are 
amplied with primers indicated in red arrows (N1-N4). FOXF1 regions with potential interactions with EnhAP1-OIS1 are 
amplied with primers indicated in green arrows (P1-P8). Agarose gel images from two independent biological 
replicates are shown with the expected sizes of the PCR products. The quantication of the gels was performed by 
normalizing to the primer eciencies. Values shown are further normalized to the quantication value of P1. B. 
Sanger sequencing results from the indicated PCR products. Csp6I restriction sites are highlighted in yellow. The 
PCR were performed using the indicated primer pairs.
Figure S7. 3C experiment reveal direct interaction between EnhAP1-OIS1 and FOXF1.
A. Genome browser presentation of the location of each primer used in 3C analysis. Constant primers 
(C1, C2) used to amplify EnhAP1-OIS1 are indicated in black arrows. Negative control regions with no 
interaction with EnhAP1-OIS1 are am lifi  with primers indicated in red arrows (N1-N4). FOXF1 egions 
with potential interactions with EnhAP1-OIS1 are amplifi ed with primers indicated in green arrows (P1-
P8). Agarose gel images from two independent biological replicates are shown with the expected 
sizes of the PCR products. The quantifi cation of the gels was performed by normalizing to the primer 
effi  ciencies. Values shown are further normalized to the quantifi cation value of P1.  B.  Sanger 
sequencing results from the indicated PCR products. Csp6I restriction sites are highlighted in yellow. 
The PCR were performed using the indicated primer pairs. 
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sgRNA-Fos sgRNA-Jun
Figure S8. Disruption of Fos and Jun could not bypass senescence. 
Representative pictures of BrdU staining experiments with sgRNAs 
against c-Fos and c-Jun genes. BJ cells were treated with 4-OHT for 14 
days. Each column shows two pictures from the same experiment.
Figure S8. Disruption of Fos and Jun could not bypass senescence. 
Representative pictures of BrdU staining experiments with sgRNAs against c-Fos and c-Jun genes. BJ 
cells were treated with 4-OHT for 14 days. Each column shows two pictures from the same experiment.
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Figure S9. FOXF1 function is independent of p53 during OIS.
A. Representative images of the SA-β-gal staining of cells under the indicated conditions and 
after 14 days 4-OHT treatment. B. The proliferation levels of the various sgRNA-transduced BJ-
in-dRASG12V cells (indicated in the figures) was quantified using BrdU assay, (* p <0.05, two-
tailed Student’s t-test). For every condition, the percentage of BrdU-positive cells was 
normalized to control cells (NT+p53 ko).
Figure S9. FOXF1 function is independent of p53 during OIS. 
A. Representative images of the SA-β-gal staining of cells under the indicated conditions and after 14 
days 4-OHT treatment. B. The proliferation levels of the various sgRNA-transduced BJ-indRASG12V cells 
(indicated in the figures) was quantified using BrdU assay, (* p <0.05, two-tailed Student’s t-test). For 
every condition, the percentage of BrdU-positive cells was normalized to control cells (NT+p53 ko). 
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Transcription as a regulator of translation
As a starting point of the study, Chapter 2 hypothesizes that promoters as the 
driving force in regulating translation. Firstly, it is recognized that transcription 
starts at a stretch of DNA sequences, which are known as promoters. Moreover, 
efficient transcription requires the presence of a promoter. Secondly, several 
studies have provided some insights into the regulatory functions of promoter 
sequences on mRNA metabolism (Bregman et al., 2011; Harel-Sharvit et al., 2010; 
Zid and O’Shea, 2014). Hence, we generated a promoter library to evaluate their 
effects on translation. To minimize any bias toward certain groups of promoters, 
we selected candidate promoters with distinct cellular functions (e.g., ribosomal 
proteins, cell cycle, transmembrane receptors, etc.). 
Moreover, since the defined promoter regions of different genes vary in length, 
we took a region of 0.5-2.5kb upstream of the main TSS for cloning. This was 
supplemented with the information of different promoter-associated histone 
modification marks (e.g., H3K9me3, H3K27Ac). This consideration covers most of 
the functional region for promoters (e.g., transcription factor binding sites, DNA 
modifications, etc.). In the promoter library, we introduced pairs of promoters with 
or without TATA box, which is originated from the β-actin promoter, to directly 
compare the effect of TATA box on translation between these promoter pairs. 
Since it is difficult to specify any endogenous TATA box within each promoter, 
we cannot exclude the presence of any intrinsic TATA boxes within the promoter 
sequence. Still, the additional TATA box should govern any changes in translation 
within the TATA box pairs. 
We noticed increased translational efficiency with an additional TATA box, despite 
further data analysis suggesting a weaker, yet significant effect upon the removal 
of the TATA box containing promoters from the promoter library. This finding 
implies that the TATA box might not be the sole factor in regulating translation 
in our experiments. Indeed, downstream experiments supported our assumption 
that TATA box is not the causal element, but that a boosted transcription rate 
could induce a more efficient translation. 
There are three things that matter in m6A: location, location, 
location.
The occurrence of RNA modifications studies emerged over 60 years ago, yet their 
biological relevance and functions have not been well characterized. With the 
rise of next-generation sequencing, genome-wide examinations of DNA and RNA 
have both become feasible and affordable. In 2012, Dominissini et al. and Meyer 
et al. developed in parallel, a method for detecting the footprints of m6A using 
anti-m6A antibodies (Dominissini et al., 2012; Meyer et al., 2012). By combining 
immunoprecipitation of m6A-bound antibody and next-generation sequencing, 
researchers have broadened our understanding of m6A biogenesis. Before our 
study, m6A was described as promoting translation by recruiting translational 
regulatory factors (eIF4F, HSP70) (Coots et al., 2017; Zhou et al., 2016). However, 
these findings were attributed to the m6A modifications in the 5’UTR or 3’UTR 
of genes, suggesting an indirect control of translation via co-factors. While we 
discovered a similar distribution of m6A in the UTR, we also identified a differential 
distribution of m6A along the coding region of genes. More importantly, we 
proposed a controversial effect of m6A on translation (repressive), possibly by 
disrupting translation elongation dynamics. This inhibitory effect on translation 
was also backed up by two studies, which showed that m6A at coding regions 
interferes with optimal codon usages (Choi et al., 2016; Hoernes et al., 2016). 
Together, we suggest that the exact functions of m6A are at least partially 
determined by its location. At UTR, m6A is recognized by m6A readers to promote 
translation actively; while at coding regions, m6A attenuates translation via 
suboptimal codon usage and impaired transcription elongation. However, further 
studies should address the significance of the locations for m6A, along with codon 
preferences during the translation process in more detail. 
Co-transcriptional deposition of m6A – two birds one stone
The mammalian cell is a very efficient factory for optimal protein production, of 
which many steps occur simultaneously. While RNA pol II is transcribing along 
the DNA, assembly of the splicing complex can already take place. Thus, it is not 
surprising to realize that the deposition of m6A exists co-transcriptionally as 
described in our study. Interestingly, this finding is further supported by the fact 
that METLL3, an m6A writer, binds to genes with high levels of m6A in multiple 
m6A profiling datasets (Knuckles et al., 2017). In our study, we performed co-
immunoprecipitation experiments to show that RNA Pol II and METLL3 interact 
during the impaired transcription elongation. 
Further studies are required to reveal the dynamics of such interaction. For 
example, protein-protein interaction experiments (e.g., FRET) could uncover 
whether the interaction is conducted continuously or in an “on and off” manner. 
Moreover, it is not well-understood if such interactions could potentially affect 
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the rate of transcription elongation and other activities of RNA Pol II. Addressing 
these aspects could provide more insight into how the interaction is established, 
and why it is found more frequently in certain conditions. 
AP1 feedback loop, a naughty boy with self-control
Characterization of the AP1 complex has been researched for decades, resulting 
in the discovery of its roles in cellular proliferation, differentiation, and cell death. 
As a well-interpreted transcription factor, AP1 is involved in many aspects of 
carcinogenesis, where it is primarily activated by various growth factors, cytokines, 
and oncogenic stimuli (Hess, 2004). In our study, we describe a more complex model 
explaining how mammalian cells respond to provide a checkpoint of tumorigenesis. 
During oncogenic RAS activation, AP1 is induced to promote cellular proliferation. 
There are various consequences for this process. First, p53 signaling pathway is 
activated and p21 locks the cells in the senescence state; second, AP1 is recruited 
to responsive elements where it induces a likely p53-independent senescence 
pathway. Thus, maintaining double insurance on cellular fitness. 
There are a few drawbacks of our study. Firstly, we did not observe any effect in 
FOS or JUN knockout cells. This could be explained by the broad functions of AP1, 
including the involvement of different family members, and association with co-
factors. As AP1 collaborates with cell-type specific transcription factors to select 
enhancers (Vierbuchen et al., 2017), it is reasonable to speculate that AP1 plays 
novel roles in the non-coding genome as well. Secondly, the senescence phenotype 
of enhancer or FOXF1 ko cells is not as potent as p53 ko cells, suggesting p53-
regulated senescence program is still dominant during OIS. The supplemental 
checkpoint by AP1-regulated senescence is possibly a failsafe mechanism to help 
arrest cells in case of a non-functional p53 pathway. Third, double knockout of 
p53 and FOXF1 boosts the level of cell proliferation versus the single knockout 
cells, indicating (at least partially) a p53-independent nature of AP1-regulated 
senescence program. Notably, the knockout of FOXF1 does not affect the p21 
protein level. Giveb the indispensable function of p53 during senescence, it will be 
difficult to dissect the effect of other regulatory elements or genes from that of 
p53 ko cells, which will likely cover any minor phenotypes. To resolve this issue, an 
appropriate model is demanded to identify the hidden regulatory networks of OIS.
Forkhead box protein, a new class of senescence modifier
Forkhead box proteins are large families of transcription factors that act on cell 
proliferation, differentiation, and senescence. To date, few studies have focused 
on the functions of Forkhead box proteins in cellular senescence. Phosphorylation 
of FOXO1 accelerates the senescence of liver in mouse (Tomobe et al., 2013). 
Protein levels of FOXA1, FOXO3, and FOXO4 are induced in senescent human 
fibroblast cells (Baar et al., 2017; Li et al., 2013). Conversely, down-regulation of 
FOXO3a stimulates the process of senescence in human fibroblast (Kyoung Kim 
et al., 2005). In our study, we discovered that FOXF1 is a positive regulator of 
senescence; however, the downstream mechanism is not well-understood.
Therefore, the exact mechanism of the regulatory role of FOX proteins during 
senescence is largely unknown, making it a matter of debate. Recently, the 
knowledge of FOX proteins has been applied to potentially reversing the process 
of aging in mammals (Baar et al., 2017). In the study, researchers developed a 
polypeptide to compete with the binding of FOXO4 to p53 in senescent cells, 
causing the exclusion of p53 from the nucleus – eventually leading to cell death. It is 
intriguing to discover that the use of the polypeptide has successfully reverted the 
fitness level and senescent phenotypes of mice. The relevance of such treatment 
for longevity in humans has yet to be carefully examined, but the functions of FOX 
proteins in senescence cannot be overlooked. 
Chapter 5 General discussion
5
115114
References
Baar, M.P., Brandt, R.M.C., Putavet, D.A., Klein, J.D.D., Derks, K.W.J., Bourgeois, B.R.M., 
Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D.A., et al. (2017). Targeted Apoptosis 
of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and 
Aging. Cell 169, 132–147.e16.
Bregman, A., Avraham-Kelbert, M., Barkai, O., Duek, L., Guterman, A., and Choder, M. (2011). 
Promoter elements regulate cytoplasmic mRNA decay. Cell 147, 1473–1483.
Choi, J., Ieong, K.W., Demirci, H., Chen, J., Petrov, A., Prabhakar, A., O’Leary, S.E., Dominissini, 
D., Rechavi, G., Soltis, S.M., et al. (2016). N6-methyladenosine in mRNA disrupts tRNA 
selection and translation-elongation dynamics. Nat. Struct. Mol. Biol. 23, 110–115.
Coots, R.A., Liu, X.M., Mao, Y., Dong, L., Zhou, J., Wan, J., Zhang, X., and Qian, S.B. (2017). 
m6A Facilitates eIF4F-Independent mRNA Translation. Mol. Cell 68, 504–514.e7.
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., Osenberg, 
S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec, M., et al. (2012). Topology of the 
human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201–206.
Harel-Sharvit, L., Eldad, N., Haimovich, G., Barkai, O., Duek, L., and Choder, M. (2010). RNA 
polymerase II subunits link transcription and mRNA decay to translation. Cell 143, 552–
563.
Hess, J. (2004). AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117, 5965–
5973.
Hoernes, T.P., Clementi, N., Faserl, K., Glasner, H., Breuker, K., Lindner, H., Hüttenhofer, A., 
and Erlacher, M.D. (2016). Nucleotide modifications within bacterial messenger RNAs 
regulate their translation and are able to rewire the genetic code. Nucleic Acids Res. 
44, 852–862.
Knuckles, P., Carl, S.H., Musheev, M., Niehrs, C., Wenger, A., and Bühler, M. (2017). RNA fate 
determination through cotranscriptional adenosine methylation and microprocessor 
binding. Nat. Struct. Mol. Biol. 24, 561–569.
Kyoung Kim, H., Kyoung Kim, Y., Song, I.-H., Baek, S.-H., Lee, S.-R., Hye Kim, J., and Kim, J.-
R. (2005). Down-regulation of a forkhead transcription factor, FOXO3a, accelerates 
cellular senescence in human dermal fibroblasts. J. Gerontol. A. Biol. Sci. Med. Sci. 60, 
4–9.
Li, Q., Zhang, Y., Fu, J., Han, L., Xue, L., Lv, C., Wang, P., Li, G., and Tong, T. (2013). FOXA1 
mediates p16INK4a activation during cellular senescence. EMBO J. 32, 858–873.
Meyer, K.D., Saletore, Y., Zumbo, P., Elemento, O., Mason, C.E., and Jaffrey, S.R. (2012). 
Comprehensive analysis of mRNA methylation reveals enrichment in 3??? UTRs and near 
stop codons. Cell 149, 1635–1646.
Tomobe, K., Shinozuka, T., Kawashima, T., Kawashima-Ohya, Y., and Nomura, Y. (2013). Age-
related changes of forkhead transcription factor FOXO1 in the liver of senescence-
accelerated mouse SAMP8. Arch. Gerontol. Geriatr. 57, 417–422.
Vierbuchen, T., Ling, E., Cowley, C.J., Couch, C.H., Wang, X., Harmin, D.A., Roberts, C.W.M.M., 
and Greenberg, M.E. (2017). AP-1 Transcription Factors and the BAF Complex Mediate 
Signal-Dependent Enhancer Selection. Mol. Cell 68, 1067–1082.e12.
Zhou, J., Wan, J., Gao, X., Zhang, X., Qian, S., and Biology, C. (2016). Dynamic m6 A mRNA 
methylation directs translational control of heat shock response. Nature 526, 591–594.
Zid, B.M., and O’Shea, E.K. (2014). Promoter sequences direct cytoplasmic localization and 
translation of mRNAs during starvation in yeast. Nature 514, 117–121.
 
SUMMARY
Summary
119118
The nature of life is intrinsically simple and complex, with merely four basic 
nucleotides that ultimately make up countless lives with distinct appearances. 
Darwin’s theory of evolution reveals how time shapes the inhabitants of the 
planet, whereby it is the fundamental components that determine who we are. It 
is not until several decades ago, where we finally cracked the mystery of the DNA 
molecule with the swirling structure. Since then, waves of biology studies have 
entered an exponential phase. With the development of technologies, scientists 
have increased their understanding of the mechanisms behind biological questions 
in various organisms. As the initial step of all biological processes, transcription 
from DNA to RNA has been extensively characterized. We have acknowledged 
that this series of action is not at all effortless, but largely regulated. To name 
a few, the state of chromatin structure, level of transcription factor binding, 
initiation, and elongation of transcription, the post-transcriptional regulation of 
messenger RNA, and not to mention the influence of non-coding RNA. Moreover, 
the messenger RNA is stepwisely exported to the cytoplasm of the cells and 
translated into protein in mammalian cells. Despite being located in two spatially 
separate compartments, the crosstalk is never ignored. 
Hence, it is of great interest to investigate whether this crosstalk between 
transcription and translation has any consequences to cellular functions. Our 
study looks at the starting point of transcription – promoter, by performing 
an unbiased screen for candidate promoters that could potentially affect the 
translation process Interestingly, we discovered a set of promoters with TATA 
box, which boosts the translation of messenger RNA. Using CRISPR-Cas9 genome 
editing, genome-wide analysis, and in vitro experiments, we found that the effect 
is not limited to promoters with TATA box. Instead it is a rather general mechanism 
dictated by the rate of transcription, more specifically transcription elongation. 
More importantly, the performance requires cap-dependent translation. To 
examine the responsible factor, we assess the level of RNA modification - m6A 
on the messenger RNA and observe a reverse correlation between the status of 
translation and the level of m6A modification. Notably, although m6A are mostly 
found around stop codons, in our study m6A modification within the coding region 
of genes are crucial for the suppressive effect on translation. Finally, we propose a 
model that co-transcriptional deposition of m6A via retarded RNA Pol II elongation 
could lead to translational control. The study opens new doors to grasping the 
hidden regulators of gene expression.
The advancement of CRISPR-Cas9 genome editing has led to a myriad of genome-
wide studies in various organisms. While most studies focus on the coding regions 
of the genome, we have previously established a systemic approach to study the 
functions of non-coding genome by targeting transcription factor binding sites at 
enhancer elements. To broaden our understanding about how enhancer elements 
coordinate gene expression, we performed a genetic screen of enhancers with 
AP1 binding motif in oncogene-induced senescence. We successfully validated 
two sgRNAs targeting the same AP1 motif, showing it can affect the process of 
senescence. Mutations of the core AP1 binding site, in turn, abolished the enhancer 
function. Later, it was discovered that the FOXF1 gene was the interacting target, 
where disruption of FOXF1 lead to similar effects on senescence. Together, we 
suggest that AP1, a downstream target of many oncogenes, maintains a negative 
feedback loop to counteract the unlimited cell proliferation driven by oncogene 
activation, thus adding an extra tier of cellular surveillance to tumorigenesis. 
SAMENVATTING
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De aard van het leven is intrinsiek eenvoudig en complex, met slechts 
vier fundamentele nucleotiden die ontelbare levens met verschillende 
verschijningsvormen codeert. Volgens Darwins evolutietheorie is onthuld hoe tijd 
de bewoners van de planeet vormgeeft, terwijl het fundamentele element dat 
codeert voor wie we zijn blijft bestaan. Pas enkele decennia geleden is eindelijk het 
mysterie van het DNA-molecuul met de helix structuur opgehelderd. Sindsdien is 
de golf van biologiestudies een exponentiële fase ingegaan. Met de ontwikkeling 
van technologieën zetten wetenschappers een grote stap richting het begrijpen 
van de mechanismen achter biologische vragen in verschillende organismen. Als 
de eerste stap van alle biologische processen is transcriptie van DNA naar RNA 
uitgebreid gekarakteriseerd. We hebben erkend dat deze reeks acties helemaal 
niet moeiteloos, maar grotendeels gereguleerd is, van de staat van de chromatine 
structuur, niveau van transcriptiefactor binding, initiatie en verlenging van 
transcriptie, tot de post-transcriptionele regulatie van boodschapper-RNA, om 
nog maar te zwijgen van de invloed van niet-coderend RNA. Bovendien wordt 
in zoogdier cellen het boodschapper-RNA stapsgewijs geëxporteerd naar het 
cytoplasma van de cellen en daar vertaald in eiwit. Ondanks dat deze zich in 
twee ruimtelijk gescheiden compartimenten bevindt, wordt de crosstalk nooit 
genegeerd.
Het is daarom van groot belang om te onderzoeken of deze crosstalk tussen 
transcriptie en translatie consequenties heeft voor cellulaire functies. We 
zetten onze voet op het startpunt van de transcriptie – de promotor - door een 
onbevooroordeelde screen uit te voeren voor kandidaat-promotors die mogelijk 
het vertaalproces zouden kunnen beïnvloeden. Interessant is dat we ontdekken dat 
een aantal promotors met TATA-boxen de vertaling van messenger-RNA stimuleren. 
Met behulp van CRISPR-Cas9 gemedieerde bewerking van het genoom, genoom-
brede analyse en in vitro experimenten onthullen we dat het effect niet beperkt 
is tot promotors met een TATA-box, maar eerder een algemeen mechanisme dat 
wordt gedicteerd door de snelheid van transcriptie, meer specifiek transcriptie-
verlenging. Wat nog belangrijker is, is dat de uitvoering een cap-afhankelijke 
translatie vereist. Om de verantwoordelijke factor te onderzoeken, beoordelen 
we het niveau van een RNA-modificatie - m6A op het boodschapper-RNA en 
observeren we een omgekeerde correlatie tussen de snelheid van translatie en 
het niveau van m6A-modificatie. Opmerkelijk is dat, hoewel meestal aangetroffen 
rond stopcodons, de M6A-modificaties in onze studie binnen het coderende 
gedeelte van genen causaal is voor het onderdrukkende effect op translatie. Ten 
slotte stellen we een model voor dat co-transcriptionele depositie van m6A via 
vertraagde RNA PolII-verlenging kan leiden tot translationele controle. De studie 
opent nieuwe deuren voor het ontdekken van de verborgen regulatoren van 
genexpressie.
De vooruitgang van CRISPR-Cas9 genoom editing heeft geleid tot een groot 
aantal genoom-brede studies in verschillende organismen. Hoewel de meeste 
studies zich richten op de coderende gebieden van het genoom, hebben we eerder 
een systemische benadering gebruikt om de functies van het niet-coderende 
genoom te bestuderen via targeting van transcriptiefactor bindingsplaatsen op 
enhancer-elementen. Om onze kennis over hoe enhancer-elementen genexpressie 
coördineren te verbreden, voeren we een genetische screening uit van enhancers 
met een AP1-bindingsmotief in door oncogen geïnduceerde senescence. We 
valideren met succes twee sgRNA’s die gericht zijn op hetzelfde AP1-motief en 
die het proces van senescence kunnen beïnvloeden. Mutaties van de kern van 
de AP1-bindingsplaats heffen de enhancer-functie op. Later ontdekken we dat 
het FOXF1-gen het interacterende doelwit is en dat verstoring van FOXF1 leidt 
tot vergelijkbare effecten op senescence. Alles samen, stellen we voor dat AP1, 
een stroomafwaarts doelwit van veel oncogenen, een negatieve feedback in 
stand houdt om de onbeperkte celproliferatie, aangedreven door activering 
van het oncogen, tegen te gaan door een extra laag van cellulair toezicht voor 
tumorgenese toe te voegen.
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